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Abstract 
Measurement error and missing data are two phenomena which prevent researchers from observing 
essential quantities in their studies. Measurement error occurs when data are subject to variability which 
masks an underlying value. Recognition of measurement error is essential to preventing bias in an 
analysis, and methods to handle it have been well-developed in recent years. However, in time-to-event 
analyses, competing risks is another important consideration which can invalidate study results if not 
properly accounted for. Current methods to accommodate competing risks do not account for 
measurement error, and, as a result, incur a large amount of bias when using covariates measured with 
error. We first propose a novel method which combines the intuition of the subdistribution model for 
competing risks with risk set regression calibration, which corrects for measurement error in Cox 
regression by recalibrating at each failure time. We show through simulations that the proposed estimator 
removes bias that occurs when measurement error is ignored. The second part of this dissertation 
addresses missing outcome data in longitudinal models. While this is a well-studied area of research, 
some current missing data methods are subject to misspecification, while others are not suited to handle 
a large amount of missing data. We propose a novel method to account for missing longitudinal outcome 
data in the situation where some patients have no recorded outcomes. We accomplish this through use 
of an auxiliary outcome available for all patients, and avoid the pitfall of misspecification by estimating its 
relationship with the data nonparametrically. We show that this method is more efficient than 
conventional methods and robust to misspecification. For both proposed methods, we show that the 
estimators are asymptotically normal, and provide consistent variance estimates. We also show that the 
estimator for the second method is consistent. We apply both proposed methods to neurodegenerative 
disease data. Finally, we introduce an R package to implement the first proposed method and make it 
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ABSTRACT
MEASUREMENT ERROR AND MISSING DATA METHODS IN BIOMARKER RESEARCH
Carrie Caswell
Sharon X. Xie
Measurement error and missing data are two phenomena which prevent researchers from ob-
serving essential quantities in their studies. Measurement error occurs when data are subject to
variability which masks an underlying value. Recognition of measurement error is essential to pre-
venting bias in an analysis, and methods to handle it have been well-developed in recent years.
However, in time-to-event analyses, competing risks is another important consideration which can
invalidate study results if not properly accounted for. Current methods to accommodate competing
risks do not account for measurement error, and, as a result, incur a large amount of bias when us-
ing covariates measured with error. We first propose a novel method which combines the intuition of
the subdistribution model for competing risks with risk set regression calibration, which corrects for
measurement error in Cox regression by recalibrating at each failure time. We show through simu-
lations that the proposed estimator removes bias that occurs when measurement error is ignored.
The second part of this dissertation addresses missing outcome data in longitudinal models. While
this is a well-studied area of research, some current missing data methods are subject to misspec-
ification, while others are not suited to handle a large amount of missing data. We propose a novel
method to account for missing longitudinal outcome data in the situation where some patients have
no recorded outcomes. We accomplish this through use of an auxiliary outcome available for all
patients, and avoid the pitfall of misspecification by estimating its relationship with the data non-
parametrically. We show that this method is more efficient than conventional methods and robust
to misspecification. For both proposed methods, we show that the estimators are asymptotically
normal, and provide consistent variance estimates. We also show that the estimator for the sec-
ond method is consistent. We apply both proposed methods to neurodegenerative disease data.
Finally, we introduce an R package to implement the first proposed method and make it widely
available for regular use.
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mated standard error; MSE = mean squared error; RE = relative efficiency.
β̂HS = estimator based on both hybrid and validation subsample; β̂CC =




Uncertainty is simultaneously a statistician’s best friend and greatest nemesis. It is the foundation
upon which all statistical principles are founded; to accept that all measured quantities have some
inherent uncertainty is what separates statistics from mathematics. On the other hand, too much
uncertainty can challenge the reliability and validity of statistical analyses. This issue of too much
uncertainty can manifest in a variety of ways. We explore here two of the most insidious forms of
uncertainty in data collection: measurement error and missing data.
Measurement error is a ubiquitous phenomenon which is often overlooked in practical situations. It
occurs when a metric is subject to variability which masks the true value of a collected data point.
For example, it is widely accepted that blood pressure should not be taken in some circumstances,
such as when a person is afraid, nervous, or has recently taken certain medications. These situ-
ations can elevate a person’s blood pressure so that a correct measurement of the person’s true
average blood pressure on a typical day will not be attainable, regardless of the accuracy of mea-
suring instruments. Blood pressure is only measured in controlled situations because it is known to
be prone to measurement error. Measurement error can occur for a variety of reasons, such as hu-
man error, variability of testing conditions, or biological fluctuations. Other biomarkers can be either
incorrectly treated as not having measurement error, or impossible to collect without measure-
ment error. Cerebrospinal fluid (CSF) is a very useful biomarker in the study of neurodegenerative
diseases, and proper handling of CSF data in statistical analyses is crucial to developing deeper
understanding of these diseases. This biomarker is often recognized as having measurement error,
but its measurement error is difficult to control. One useful way of controlling for the variability that
causes measurement error is to collect replicate data. Risk set regression calibration (RRC; Xie,
Wang, and Prentice 2001) is an appropriate statistical method to account for measurement error
through utility of replicate data in time-to-event analyses.
One of the biggest challenges in analyzing neurodegenerative disease data with a time-to-event
model is competing risks. A competing risk is an event which can potentially affect many patients in
a population and which precludes the event of interest. For example, when studying time to some
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disease-related event in a population with a high-mortality disease, death should be considered a
competing risk, because patients who die will not experience the event of interest. In this sense,
competing risks can be viewed as a form of missing data, because they prevent investigators from
observing outcomes for all patients on a study. Current literature does not offer a statistical method
to account for both competing risks and measurement error in survival analysis. In Chapter 2, we
present a novel method to do this.
The other form of uncertainty in this dissertation, missing data (specifically missing outcomes), is
addressed in Chapter 3. Here, we leave the realm of survival analysis in favor of a related setting,
longitudinal studies. Missing outcomes is a very common problem in these studies, primarily be-
cause patient dropout is nearly inevitable. However, in this chapter, we explore an additional form
of missingness in longitudinal studies. When the outcome is difficult or impossible to measure due
to limitations of the study design or resources, then the amount of missing data on the study can
be significantly greater than that of a typical patient dropout scenario. For example, the outcome
of the study in Chapter 3 is measured by MRI; however, many study sites do not have adequate
facilities to perform MRI scans. Patients randomized to these sites are missing outcome data at
all timepoints, and have only covariate data to be entered into an analysis model. While statistical
methods to account for missing data is an extensive and ever-evolving area of research, the current
conventional methods to handle missing data are not suited to address datasets with such a large
amount of missing data in a longitudinal setting. Therefore, we present a novel method to address
this dearth of outcome data by using an auxiliary outcome which is correlated with the missing
outcome.
Finally, Chapter 4 presents a software package which implements the method of Chapter 2, making
it widely available for users of all levels of expertise. The Appendices give proofs for the asymptotic
properties of all proposed estimators of Chapters 2 and 3, as well as additional simulations to
supplement Chapter 3. Concluding remarks are given in Chapter 5.
2
CHAPTER 2
ADJUSTING FOR COVARIATE MEASUREMENT ERROR IN FAILURE TIME MODELS
UNDER COMPETING RISKS
2.1. Introduction
Biomarker research can be fraught with challenges, particularly when biomarkers of a certain dis-
ease are known to be measured with error. Failure time analysis is a popular model choice for these
situations, necessitating methods which can reliably correct for measurement error and other data
features in a survival analysis setting. For example, in the study of neurodegenerative diseases
such as Alzheimer’s disease (AD), biomarkers are extracted from cerebrospinal fluid (CSF) and
analyzed through assays. Measurement error can be incurred in these samples through a variety
of sources, including, but not limited to, day-to-day fluctuations in the CSF, plate-to-plate variability
in assay development, variable storage conditions, and operator error. These conditions render
the true value of the biomarker unobservable, and inhibit the ability of statisticians to estimate true
regression coefficients accurately in Cox models. As medical research continually advances our
understanding of CSF biomarkers, reliable and accurate estimation methods are of the utmost im-
portance for efficient and effective treatment of patients. Statistical advancements in this field can
be applied to the study of any disease marked by measurement error-prone biomarkers.
A number of methods for correcting measurement error have been published in recent years. Or-
dinary regression calibration (Prentice, 1982) operates by attenuating the hazard toward its true
value, using the conditional expectation of the true covariates given the observed covariates. Pren-
tice (1982) also demonstrated that ignoring measurement error in the covariates can produce con-
siderable bias. Many applications of this method have been widely cited, notably by Tsiatis, De-
Gruttola, and Wulfsohn (1995). Xie, Wang, and Prentice (2001) proposed an expansion of ordinary
regression calibration, risk set regression calibration (RRC), which recalibrates at each failure time
using only the subjects in the risk set at that time. RRC adjusts time-independent covariates, cre-
ating new true covariate estimates at each failure timepoint. It has been shown to perform well in
simulations, including in a joint modeling framework (Ye, Lin, and Taylor, 2008).
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Neurodegenerative diseases and other terminal illnesses are often studied among populations with
a high mortality rate. As AD tends to affect the elderly population, many patients who have not
yet developed clinical AD, but may do so at a future time, will pass away of unrelated causes
prior to symptom onset. Therefore, it is appropriate to analyze these data with a competing risks
framework. Lu (2017) has developed a Bayesian framework to address these concerns in a joint
survival longitudinal model setting. However, Lu’s method cannot be directly applied to the Cox
model, which is the focus of our paper.
Moeschberger, Tordoff, and Kochar (2008) provide a thorough review of competing risks methods.
There are two primary methods most often used in practice. Cause-specific hazard models use a
hazard which only considers the event of interest in its calculation. Models for this method are inter-
preted in a similar way to a model which does not account for competing risks (Dignam, Zhang, and
Kocherginsky, 2013). These models are useful when the question of interest involves multi-state or
transition models, or when multiple event types carry equal interest. However, when dealing with
an elderly population and disease diagnosis, often the diagnosis is the only event of interest, and
death is a nuisance event. Furthermore, clinicians and researchers are often interested not only
in the hazard associated with an event of interest among competing events, but also in the inci-
dence of this event. Despite the intuitive construction of the cause-specific hazard, it has no direct
association with cumulative incidence. Therefore, analyses performed within the cause-specific
framework must be interpreted with caution and must not be extended to cumulative incidence. On
the other hand, the regression coefficient for a covariate in a proportional subdistribution hazards
model provides information about the direction and significance of the covariate effect on cumu-
lative incidence, because this coefficient can be thought of as coming from a generalized linear
model for the cumulative incidence function with a complementary log-log link (Austin and Fine,
2017). Therefore, while estimators must always be interpreted carefully under competing risks, it is
beneficial to have some insight about the cumulative incidence in the original analysis. For these
reasons, we chose to use the subdistribution hazard ratio estimator, proposed by Fine and Gray
(1999), for our model.
Fine and Gray used a modified hazard based on a subdistribution of the event of interest. Let T
be the failure time for any event and ε ∈ 1, 2, . . . ,H denote the type of event among H possible
events, with ε = 1 the event of interest. Define a vector Z as an s x 1 time-independent vector of
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covariates, where s is the number of covariates in the model. The subdistribution hazard for failure




P (t ≤ T ≤ t+ ∆t, ε = 1|T ≥ T ∪ {T ≤ t ∩ ε 6= 1},Z). (2.1)
This induces a subdistribution F1(t;Z) = P (T ≤ t, ε = 1), which has an upper limit of P (ε = 1) as
t→∞, in contrast with the traditional distribution function’s upper limit of 1. In this sense, λ1(t;Z) is
the hazard function for the improper random variable T ∗ = I(ε = 1)×T +{1−I(ε = 1)}×∞, where
I is the indicator function. The risk set for this hazard function includes the usual subjects who have
not failed or been censored at time t, in addition to all subjects that have failed of events 2, . . . ,H at
any time on the interval [0,∞). This improper risk set is the key tenant of the subdistribution model,
and it is what sets it apart from other competing risks methods. This also makes it an ideal method
for combination with RRC: the estimates produced by RRC can become unstable if the risk set
becomes too small. If fewer than 20 subjects are at risk, then estimates from previous timepoints
are carried through (Xie, Wang, and Prentice, 2001). However, improper risk sets are unlikely to
shrink very much toward the end of a study, because failures due to nuisance events remain at risk
throughout the study period.
There are five new contributions to the literature from this paper. First, we propose an estimator
for the regression coefficients in a Cox regression model (Cox, 1972) which accounts for covariate
measurement error in the presence of competing risks. Our estimator uses the time-dependent
RRC estimates for the true covariates at each timepoint, thereby assuming possible measurement
error but not requiring it. Covariates measured without error can be included in the model as
well. Furthermore, our method substitutes the traditional hazard function from the Cox model with
λ1(t;Z) and its corresponding improper risk set. This risk set offers stability to the RRC estimates
as well as an avenue for competing risks estimation in the presence of measurement error. Sec-
ond, this paper makes a substantial contribution to the scientific field of biomarker research in AD.
Previously, researchers have examined associations between CSF biomarkers and risk of develop-
ing AD among ADNI data, because this question is important for drug discovery and clinical trials
(Jack et al., 2010). However, typically these studies have not utilized multiple replicates per subject,
opting instead to reduce the set of replicates to a single statistic (such as median or mean) for each
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subject. Data reduction by this naive approach results in a significant loss of information as well
as opportunity to analyze data more rigorously. We are among the first to use the complete set of
replicates in this data, thereby contributing a novel data analysis which is consistent with current
scientific knowledge and may help to elucidate further discoveries in this therapeutic area. Third,
our proposed estimator reduces bias incurred by competing risks estimators when measurement
error is ignored. The effects of ignoring measurement error in the subdistribution hazard ratio esti-
mator are directly compared to the reduced bias of our proposed estimator through simulations. We
examined a variety of practical conditions, including different magnitudes of hazard ratios and mea-
surement error variance, as well as different sample sizes. Fourth, failure to recognize the threat of
competing risks can inhibit accurate risk estimation in elderly populations. Often when biomarkers
are known to be measured with error, competing risks are ignored in favor of reducing the bias that
comes with ignoring measurement error. Our proposed method offers greater flexibility than tradi-
tional RRC estimation by accounting for multiple failure types. Our proposed estimator can handle
random right censoring, and can be extended to incorporate left truncation and time-dependent
covariates as well, making it a versatile option in many traditional survival analysis studies. Finally,
we develop and provide rigorous proof for the asymptotic distribution theory on a continuous time
interval at all possible timepoints, subject to regularity conditions outlined in the appendices. We
also provide a consistent estimator for the asymptotic variance.
Section 2.2 of this paper outlines the details of the proposed new method. Sections 2.3 and 2.4
corroborate claims with simulation results and a worked data example. Section 2.5 discusses
possible extensions of the proposed method.
2.2. Proposed Methods and Asymptotic Results
For each subject i, let Ti denote the failure time, and Ci the censoring time, i = 1, . . . , n. Assuming
there are H observable failure types, Ti is the common failure time notation for any failure of type
1, . . . ,H, with εi ∈ (1, . . . ,H) to distinguish the respective failure type. Consider failure type 1
to be the event of interest. We observe Xi = min{Ti, Ci}, the minimum of the subject’s failure
time and censoring time. Let δi = I(εi = 1, Ti ≤ Ci). We denote for each subject an s x 1 true
covariate vector Zi, which is time-independent. Adopting the subdistribution function framework,
let Ni(t) = I(Xi ≤ t, εi = 1), the counting process for the event of interest subject i. Thus, the
6
at-risk process is Yi(t) = 1−Ni(t−). For any time t, the risk set for failure type 1 includes subjects
whose failure or censoring time has not yet been observed right before time t as well as subjects
who have already failed of any event type εi 6= 1. Assume that we observe data on an interval of
continuous time from 0 to some maximum timepoint M , that Ci is independent of Ti conditional on
the covariates Zi, and that the censoring distribution does not depend on the covariates.
Under the classical measurement error model, we do not observe the true covariate Zi for any
subject i. Instead, for j = 1, . . . , ki replicates of the covariate measurement for subject i, ki =
1, . . . , `, where ` is the maximum number of replicates that can be attained by a single subject on
the study, we observe
Wij = Zi + ζij .
In the above, ζij are independent and identically distributed random variables with mean 0 and
variance σ2, and ζij are independent of Zi values.
The risk set regression calibration estimator of Xie, Wang, and Prentice (2001) relies on within-
subject and between-subject variance estimation at each timepoint. First, the within-subject vari-






(Wij −W i)(Wij −W i)′,
whereW i is the average of the ki replicates for subject i, and ñ =
∑n
i=1(ki−1). Next, the between-

























Then the measurement error-corrected estimate for covariate Zi at timepoint t can be constructed
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in the following way:









τ̂ki(t) = Σ̂(t){Σ̂(t) + ∆̂k−1i }
−1.
The estimate Ẑi(t) can be thought of heuristically as the sum of two quantities: first, the observed
overall covariate mean at time t attenuated by the proportion of the total variance attributable to
within-subject variability; second, the observed covariate mean for subject i attenuated by the pro-
portion of the total variance attributable to between-subject variability. Xie, Wang, and Prentice
(2001) note that the above can be obtained through a least squares estimation procedure, or by
temporarily assuming that (Zi,W i) have a joint normal distribution, in which case Ẑi(t) is the condi-
tional expectation of Zi givenW i at time t. Furthermore, this method can accommodate covariates
measured without error along with those measured with error. For simplicity of notation, covariates
measured without error can be included in the vector W i, so that the off-diagonal elements of Σ̂(t)
capture the covariance among all covariates. Since there is no within-subject variability for those
covariates measured without error, the corresponding elements of ∆̂ are 0.
We propose a new estimating equation to simultaneously account for covariate measurement error
and competing risks. Our proposed estimating equation is based on the subdistribution hazard ratio
estimator proposed by Fine and Gray for competing risks, with the modification that each covariate
Zi is replaced with its RRC estimate, Ẑi(t), which is the estimated expected value of Zi at each
timepoint. Let ri(t) = I{Ci ≥ (Xi ∧ t)} and wi(t) = ri(t)Ĝ(t)/Ĝ(Xi ∧ t), as defined in Fine and
Gray (1999), where G(t) is the survival function associated with the censoring process, and Ĝ(t)
is its Kaplan-Meier estimator. Consider the Cox model λ1(t;Z) = λ10(t)exp(βTZ), where λ10(t) is
the baseline hazard for failure type 1, and β is a s x 1 vector of regression coefficients. The new
















A shorthand for this equation can be created by defining the following:




⊗pexp(βT Ẑj(t)), for p = 0, 1, 2.












Using established convergence in Xie, Wang, and Prentice (2001), it can be noted that β̂C−RRC
p−→
β∗ as n→∞, where β∗ 6= β0 and β0 is the true value of β. Therefore, our new estimator will retain
some asymptotic bias in estimation. However, we will show through simulations that this bias is
very small under a variety of practical situations. We also show that our new estimator significantly
reduces the bias of the subdistribution hazard ratio estimator.
Additionally, we show in Appendix A.1 that n−1/2UC−RRC(β) is asymptotically equivalent to a sum
of independent, identically distributed random variables. Therefore,
n1/2(β̂C−RRC − β∗) is asymptotically normally distributed with mean 0 and covariance matrix
A−1(β∗)B(β∗)A−1(β∗) as n → ∞. Definitions of matrices A and B along with their consistent
estimates are provided in A.1. This asymptotic variance is used to obtain standard error estimates
of the proposed estimator in the simulations and data example.
2.3. Simulation
A cohort of n = 200 subjects was generated along with failure times, censoring times, and failure
types according to the algorithm described in Fine and Gray (1999). To detail the algorithm, a single
covariate was generated for each subject, and H = 2 failure types were considered. Denote β0 the
true regression coefficient for type 1 failures, the event of interest; β2 is the true regression coef-
ficient for type 2 failures, the nuisance event. The subdistribution for type 1 failure was generated
from an exponential mixture distribution as
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P (Ti ≤ t, εi = 1|Zi) = 1− [1− p{1− exp(−t)}]exp(β
T
0 Zi).
where p is a parameter specifying the mixture weight. Following this, P (εi = 1|Zi) can be obtained
by taking the limit as t→∞ to obtain
P (εi = 1|Zi) = 1− (1− p)exp(β
T
0 Zi).
Then, t can be solved for using the relation P (Ti ≤ t, εi = 1|Zi) = P (Ti ≤ t|εi = 1, Zi)P (εi =
1|Zi) and the fact that P (Ti ≤ t|εi = 1, Zi) is a uniform(0,1) random variable. Type 2 failure
times were generated from an exponential distribution with rate parameter exp(βT2 Zi). Failure type
was ultimately decided using a Bernoulli distribution with probability parameter P (εi = 1|Zi). All
values for β̂SHR, the logarithm of the subdistribution hazard ratio estimator, were obtained using
the cmprsk package in R version 3.3.2. Since this package does not accommodate replicate
data, we used the median of the replicate covariate values for each subject in the calculation of
βSHR. Varying degrees of measurement error were applied using the noise-to-signal ratio (NSR),
calculated as (σ2/k)/Var(Z), where k is the number of replicates per subject. In all simulations, k =
4 and the distribution of Z was chosen such that Var(Z) = 1. Therefore, in these simulations, we
vary the NSR by varying only σ2. An NSR value of 0.05 was chosen to emulate the magnitude
of measurement error variance in our data example. Values of 0.2, 1, and 4 were chosen for
σ2, to produce respective NSR values of 0.05, 0.25, and 1. All results were obtained using 1000
simulation replicates. The standard error for β̂C−RRC was calculated using the formula for the
asymptotic variance of the estimator found in Appendix A.1. Tables 2.1 and 2.2 display the bias
(β̂−β0), empirical standard deviation of estimates across the 1000 simulation runs (SD), estimated
standard error (ŜE) obtained from asymptotic variance, mean squared error (MSE), and coverage
of 95% confidence intervals (COV).
The results of the first simulation are displayed in Table 2.1. Z is distributed as N(0,1). Censoring
times were generated from a uniform(0.5,2) distribution and p set to 0.3, to produce approximately
30% censoring. Values of β0 were chosen to give a hazard ratio of 2 and 3, respectively. In all
simulations, β0 and β2 (not shown) are equal. It is apparent that the bias of β̂SHR exceeds that
of β̂C−RRC in every parameter combination. In fact, the bias of β̂SHR increases to roughly 50% of
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Table 2.1: β̂C−RRC is the proposed estimator; β̂SHR is the logarithm of the subdistribution hazard
ratio estimator. Bias = β̂ − β0. SD = empirical standard deviation of estimates across the 1000
simulation runs. ŜE = estimated standard error. MSE = mean squared error. COV = coverage of
95% confidence intervals. In all simulations, β2 (not shown) is equal to β0. Z is a N(0,1) random
variable. NSR = noise-to-signal ratio, defined as (σ2/k)/Var(Z), where each subject has k = 4
replicates. HR = hazard ratio.
n=200
NSR = 0.05 NSR = 0.25 NSR = 1.00
β0 Parameter β̂C−RRC β̂SHR β̂C−RRC β̂SHR β̂C−RRC β̂SHR
0.6931 (HR = 2) Bias 0.010 -0.027 0.012 -0.140 0.360 -0.355
SD 0.161 0.152 0.183 0.139 0.276 0.109
Mean(ŜE) 0.156 0.147 0.176 0.134 0.263 0.105
MSE 0.024 0.022 0.031 0.038 0.070 0.137
95% COV 0.943 0.930 0.938 0.784 0.957 0.107
1.0986 (HR = 3) Bias 0.007 -0.054 -0.005 -0.255 0.013 -0.603
SD 0.170 0.158 0.194 0.140 0.324 0.104
Mean(ŜE) 0.159 0.149 0.184 0.133 0.308 0.101
MSE 0.025 0.025 0.034 0.083 0.095 0.374
95% COV 0.939 0.917 0.940 0.483 0.938 0.001
the value of β0 when σ2 increases. When the NSR is 0.05 (very small measurement error), the
bias from β̂SHR is small. The standard error from β̂C−RRC is only marginally larger than that from
β̂SHR. The MSE are almost identical for both methods. When the NSR is 0.25 or higher (moderate
to large measurement error), β̂SHR exhibits considerable bias and the corresponding confidence
interval is very inaccurate. β̂C−RRC performs well with little bias and excellent confidence interval
coverage. β̂C−RRC has a larger standard error than β̂SHR due to an additional component to be
estimated in its score equation. However, MSE(β̂C−RRC) is smaller than MSE(β̂SHR), indicating
that the increase in bias of β̂SHR is large enough to overcome its smaller standard error. This is
evident in the fact that the coverage probability for β̂SHR plummets to 0 quite quickly, particularly
at large values of β0 and large σ2. The coverage probability for β̂C−RRC holds near or above 90%
for all simulations. This stark difference in coverage reveals that confidence intervals for β̂SHR
should generally not be trusted in practice when the dataset contains a moderate to large amount
of measurement error, despite the fact that the confidence intervals for β̂C−RRC under the same
conditions will be slightly wider. Therefore, we can consider both the confidence intervals and the
point estimates from β̂C−RRC to be more robust to unfavorable conditions than β̂SHR.
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Table 2.2: β̂C−RRC is the proposed estimator; β̂SHR is the logarithm of the subdistribution hazard
ratio estimator. Bias = β̂ − β0. SD = standard deviation of estimates across the 1000 simulation
runs. SE = standard error. MSE = mean squared error. COV = coverage of 95% confidence
intervals. In all simulations, β2 (not shown) is equal to β0. Z is a uniform(0,
√
12) random variable.
NSR = noise-to-signal ratio, defined as (σ2/k)/Var(Z), where each subject has k = 4 replicates. HR
= hazard ratio.
n=200
NSR = 0.05 NSR = 0.25 NSR = 1.00
β0 Parameter β̂C−RRC β̂SHR β̂C−RRC β̂SHR β̂C−RRC β̂SHR
0.6931 (HR = 2) Bias 0.003 -0.031 -0.014 -0.156 -0.009 -0.369
SD 0.209 0.198 0.218 0.169 0.302 0.126
Mean(ŜE) 0.198 0.188 0.209 0.162 0.287 0.122
MSE 0.039 0.036 0.044 0.051 0.083 0.151
95% COV 0.945 0.942 0.935 0.814 0.944 0.172
1.0986 (HR = 3) Bias -0.014 -0.073 -0.049 -0.285 -0.039 -0.620
SD 0.159 0.149 0.177 0.127 0.307 0.093
Mean(ŜE) 0.157 0.147 0.170 0.123 0.277 0.089
MSE 0.025 0.027 0.031 0.097 0.078 0.393
95% COV 0.952 0.907 0.927 0.350 0.905 0.001
In Table 2.2, the same simulation was performed with covariates generated from a
uniform(0,
√
12) distribution, to assess the performance of the estimator under non-normally dis-
tributed covariates. The upper limit of the uniform distribution was chosen to guarantee that the
covariate has a variance of 1. Censoring was maintained at approximately 25%, with censoring
times generated from a uniform(0.2,1) distribution and p = 0.1. Once again, we see that the 95%
coverage probability of β̂SHR falls well below 95%, particularly at increasing magnitudes of β0 and
σ2. This implies that confidence intervals obtained from this method without accounting for mea-
surement error will not give the desired coverage. In contrast, β̂C−RRC once again performs well,
with a larger standard error but stable MSE. All simulations were performed with n = 200 subjects
and repeated with n = 100 subjects to demonstrate the performance of the estimators at a smaller
sample size (n=100 results are included in Appendix A.2). All results were similar between the two
sample sizes.
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2.4. Analysis of Association Between CSF Biomarkers and Risk of Conversion to
AD
Motiving data comes from the Alzheimer’s Disease Neuroimaging Initiative (ADNI), a multisite, on-
going longitudinal study which validates the use of biomarkers for AD diagnosis and clinical trials
(Weiner et al., 2012). This example analyzes data collected from the start of the study in 2004 up to
September 1, 2016. Our primary scientific question is how CSF biomarkers are related to the risk
of conversion to AD. Each patient underwent at least one CSF collection; most patients returned
annually for subsequent collections. Samples of CSF were divided into many subsamples, and all
but one were frozen immediately after collection. When a patient returned for the next collection,
one of the previous subsamples was processed and CSF biomarkers were measured. Therefore,
each patient’s number of replicates of the baseline measurement is equal to the number of visits.
In addition to biomarker collection, patients also underwent a clinical exam at each visit. Conver-
sion to AD was recorded based on clinical exams. The event of interest is first diagnosis of AD;
death is considered the competing event. Time 0 is defined as study entry. A total of 1064 subjects
entered the study without AD; of those, 211 converted to AD during the study, and 79 died without
conversion to AD. This results in a ratio of death to AD of 0.37, which is comparable to the ratio of
nuisance event to event of interest featured in Fine and Gray (1999), which was 0.42. The sample
of patients is largely elderly, with mean age 73 (SD = 7.1). Patients without a record of death or
conversion to AD were considered right-censored at the date of the most recent clinical cognitive
exam. Demographics are summarized by gender in Table 2.3.
The methods of Section 2.2 were implemented to answer the above scientific question. In this
situation, censoring does not include death, but includes random occurrences, such as moving
geographic locations, that may lead to a loss to follow-up. Therefore, the study design does not lead
us to believe that the censoring distribution depends on the covariates. Because recent literature
cites evidence that abnormalities in amyloid-β (Aβ) are detectable earlier in the disease stage than
abnormalities of other CSF biomarkers (Jack et al., 2010), Aβ was chosen as the CSF biomarker
covariate for this model. The original unit of measurement for Aβ is pg/mL, but the variable was
rescaled by dividing each value by 100 to allow easier interpretation. Tables 2.3 and 2.4 reflect
the rescaled values. The remaining covariates, which are not assumed to have measurement
error, are gender, age (years) at study entry, education (years), and presence of ApoE4 gene. The
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Table 2.3: Continuous variables summarized with mean and standard deviation in parentheses;
categorical variables summarized with counts and percentages in parentheses.
Predictor Male Female
N 587 477
CSF Aβ (100 pg/mL) 1.76 (0.56) 1.80 (0.55)
Age (years) 74.0 (7.0) 72.2 (7.1)
Education (years) 16.6 (2.8) 15.5 (2.7)
ApoE4
0 325 (55.4%) 271 (56.8%)
1 204 (34.8%) 169 (35.4%)
2 58 (9.9%) 37 (7.8%)
Conversions to AD (Yes/No) 126 85
Deaths (Yes/No) 53 26
Ratio of Death Counts to AD Counts 0.42 0.31
corresponding elements of ∆̂ are 0 for these covariates measured without error; thus, it can be
seen in equation 2.2 that Ẑi(t) = W i,∀i, t, for all covariates except Aβ. To calculate the NSR for
this dataset, we obtained Σ̂(t) evaluated at t = 0, the baseline measurement. We consider Σ̂(t)
evaluated at t = 0 to be an appropriate estimate for Var(Z), because all subjects are in the risk
set at baseline. We calculated V̂ar(Z) = 0.2725 and ∆̂=0.0198. The NSR is then ∆̂/V̂ar(Z) =
0.07, as noted in Section 2.3. This low NSR is consistent with NSRs found across normal, MCI,
and AD patients in other published studies using ADNI data (White, Shaw, and Xie, 2016). Results
can be found in Table 2.4. Ties in event times were accounted for using Breslow’s approximation
(Kalbfleisch and Prentice, 1980). For the subdistribution model, each subject’s single Aβ value was
taken to be the median of his/her baseline replicate values. To assess the assumption of additive
measurement error, we employed the procedure of (White and Xie, 2013), by plotting intra-subject
standard deviations against means (not shown). We found no discernible patterns, indicating that
the additive error assumption is not violated.
We have seen in Section 2.3 that β̂SHR has small bias when the measurement error in the dataset
is small, a condition which holds in this example. In this analysis, both β̂C−RRC and β̂SHR are com-
parable in both magnitude and standard error; however, we do see attenuation toward 0 of β̂SHR.
Furthermore, the confidence intervals for the Aβ coefficient do not include 0 by either method.
Whether an investigator uses the proposed method or the SHR method, he or she would conclude
that lower levels of Aβ are significantly associated with risk of conversion to AD, a conclusion which
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Table 2.4: β̂C−RRC is the proposed estimator; β̂SHR is the logarithm of the subdistribution hazard
ratio estimator. ŜE = estimated standard error. CI = confidence interval.
β̂C−RRC β̂SHR
Predictor Estimate ŜE 95% CI Estimate ŜE 95% CI
CSF Aβ -1.525 0.190 (-1.897, -1.152) -1.426 0.175 (-1.768, -1.083)
Age -0.013 0.011 (-0.035, 0.009) -0.012 0.011 (-0.034, 0.010)
Gender 0.081 0.148 (-0.209, 0.372) 0.088 0.148 (-0.202, 0.378)
Education -0.003 0.026 (-0.054, 0.048) -0.004 0.026 (-0.055, 0.047)
ApoE4 0.169 0.116 (-0.057, 0.396) 0.210 0.112 (-0.009, 0.430)
is consistent with previous studies (Shaw et al., 2011). The similarity between these two estimates
is confirmed in the simulation results of Section 2.3, where it was shown that bias for β̂SHR is low
and the coverage probability is above 90% for both methods with a low NSR of 0.05. As we can see
from Section 2.3, the proposed method works well, removing bias and leading to valid conclusions,
regardless of the magnitude of measurement error variance. While the subdistribution model has
similar conclusions in this data example due to the small amount of measurement error, it does not
make full use of the available replicate dataset and runs the risk of generating incorrect conclusions
if the measurement error were larger. Thus, we recommend using the proposed method whenever
covariate replicate data is available in practice.
2.5. Discussion
The proposed method implemented in this paper removes bias incurred by the subdistribution haz-
ard ratio estimator caused by covariates measured with error. It accomplishes this by recalibrating
at each time where an event of interest occurred, using only the subjects in the risk set at that
time. It is evident in Section 2.3 that this bias of β̂SHR is significant, especially when the amount
of measurement error is moderate or large. Furthermore, the coverage probability of the subdistri-
bution model is very sensitive to both measurement error and the magnitude of the true regression
coefficients. Although the subdistribution model has been groundbreaking in addressing compet-
ing risks, this bias can be removed almost completely by simultaneously accounting for covariate
measurement error. Our proposed method has robust coverage probability that is only marginally
impacted by extreme conditions, and remains high under reasonable circumstances. Additionally,
the MSE for our proposed method is better than or on par with that of β̂SHR. This indicates that the
increased variance that results from estimating an extra component of the score equation does not
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eclipse the decrease in bias. We recommend use of our proposed method whenever replicate data
is available, as our method will provide valid conclusions in the presence of measurement error
whose variance ranges from small to large in magnitude.
Although not presented in this paper, our proposed method can be extended to incorporate left-
truncated data, which often occurs in studies where patients have delayed entry into the study
(i.e., entering after time 0). In this situation, the risk set can be redefined to include only subjects
who entered after the truncation time, in addition to the risk set constraints described in Section
2.2. Although we present the proposed method in the context of time independent covariates, it
is straightforward to model time-dependent covariates by recalibrating in a similar fashion. There
are some limitations to our method which require further exploration. First, our method requires
replicate data. Not all subjects need to have more than one replicate, but it is necessary that a sub-
set of them do. Replicate data is available from ADNI, but other studies may have more difficulty
accessing or collecting replicate data. However, our method can be extended to include external
validation datasets to circumvent this problem. Second, our method assumes a classical measure-
ment error model, where errors are additive and independent. Our method can be extended to
encompass correlated measurement errors, for situations where the classical measurement error
model is not appropriate. However, even when we use the classical measurement error model, we
do not require that the measurement error or covariates be normally distributed. This is because
the RRC estimates can be derived using a least squares method, rather than assuming normality,
as mentioned in Section 2.2 (Xie, Wang, and Prentice, 2001).
The methods in this paper carry important clinical implications. Failure to employ a robust estima-
tion method will often result in misleading or incorrect conclusions. In a clinical setting, this can
lead to squandering valuable resources by treating too many patients whose risk for conversion to
AD was overestimated, or neglecting to treat patients whose true risk for AD was underestimated.
In either case, the burden that AD imposes on patients, families, caregivers, and society will po-
tentially increase. Additionally, as the intricate relationship between biomarkers and AD becomes
better understood, it is paramount that statistical methods can remain on par with ongoing medi-
cal advances. By accounting for covariate measurement error in the presence of competing risks,
we can utilize a reliable and accurate estimation procedure which addresses these challenges.
Our method can be applied to any disease study with measurement error-prone biomarkers and a
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population subject to multiple failure types.
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CHAPTER 3
EFFICIENT LINEAR LONGITUDINAL MODELS IN THE PRESENCE OF MISSING
OUTCOMES
3.1. Introduction
Linear mixed-effects models have long been an invaluable tool in analyzing longitudinal data. Ever
since the theory and estimation for these models was made widely available by Laird and Ware
(1982), they have provided a crucial pathway for characterizing individual effects on population
means, and remain a popular choice of analysis for clinical trials. However, the persistent challenge
of missing data in longitudinal studies does not discriminate by model type. This ongoing problem
demands continued improvements in research, in order to ensure that investigators can evaluate
the effects of the predictors in their studies in the most efficient and reliable way possible.
Despite the many strides made in the approach to handling missing outcomes, complete case
analysis (CCA) remains the default approach in many software packages. CCA estimates are
unbiased when the outcomes are missing completely at random (MCAR); however, the omission of
observations from the analysis results in a loss of efficiency and power that can make the difference
between success and failure in a clinical trial. Such a critical flaw necessitates appropriate methods
to incorporate the incomplete cases into the analysis.
A very popular choice is multiple imputation (MI), first introduced by Rubin (1987). MI has proved to
be an efficient way to analyze data (Ibrahim et al., 2005), and many variations of the approach have
been developed over the years, including predictive mean matching (Schenker and Taylor, 1996)
and multiple imputation with chained equations (Erler et al., 2016). In the absence of a definitive
“gold standard” for missing data analyses, MI and its variations remain the conventional choice for
handling missing data in a variety of situations. While these methods improve efficiency compared
to CCA (Ibrahim et al., 2005; Qi and Sun, 2014), they require parametric assumptions in addition
to the parameters of the regression model. For example, MI requires specifying a relationship
between the covariates and missing outcome in order to impute missing values; predictive mean
matching (PMM) uses an assumed model in order to compute the predicted means, which are used
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to select an imputed value from the set of complete cases. Misspecification of the assumed model
in MI methods can lead to biased results (Schenker and Taylor, 1996; Tomita, Fujisawa, and Henmi,
2018).
Other analysis choices include weighted estimating equations, Bayesian methods, and inverse
probability weighting (IPW). These analyses are all either parametric or semiparametric, and thus
subject to the same vulnerabilities (Ibrahim et al., 2005; Qi and Sun, 2014). IPW can be used
nonparametrically, by estimating the weights from the data; however, IPW methods are subject
to inefficiency and bias in a variety of situations (Clayton et al., 1998; Carpenter, Kenward, and
Vansteelandt, 2006). An augmented IPW (Robins, Rotnitzky, and Zhao, 1994; Scharfstein, Rot-
nitzky, and Robins, 1999) has an attractive doubly robust property that the other methods lack.
These methods have been extensively evaluated in literature (Seaman and Vansteelandt, 2018;
Kang and Schafer, 2007). We offer an alternative robust approach that avoids placing parametric
restrictions when accounting for missing data by using an auxiliary outcome. In other words, our
new approach does not require additional parametric assumptions besides the standard assump-
tions from the mixed-effects model.
Use of an auxiliary outcome offers a way to incorporate all observations into an analysis, complete
or incomplete, by taking advantage of the information contained in the relationship between the
auxiliary outcome and the true outcome. Pepe (1992) developed a method which takes advantage
of an auxiliary outcome by nonparametrically estimating its relationship to the true outcome, thereby
avoiding the pitfall of misspecification altogether. Pepe, Reilly, and Fleming (1994)’s mean score
method similarly takes advantage of auxiliary data without placing restrictions on its relationship to
the missing outcome. Both methods were developed for cross-sectional studies.
This article is motivated by the Parkinson’s Progression Markers Initiative (PPMI), the largest on-
going, prospective, biomarker-rich longitudinal study in early Parkinson’s disease (PD). The data
from this study present a promising avenue for advances in PD research. The study collects a
variety of useful endpoints, one of which is magnetic resonance imaging (MRI). Our scientific aim
is to estimate the longitudinal change in gray matter volume over time measured by MRI. However,
some participating study sites lack the facilities to perform research-quality MRI scans. As a result,
many study subjects (about 60%) are missing an MRI scan at all visits. Removing these subjects
from the analysis would greatly reduce the sample size of the study and the efficiency of any re-
19
gression estimates. Additionally, while MI is a possible choice for analyzing this data, the significant
proportion of subjects without MRI scans calls into question the efficiency of MI or PMM estimates,
as datasets with a small number of complete cases can lend to instability in MI or PMM estimates
(Schenker and Taylor, 1996).
We propose a novel method for longitudinal data with a missing continuous outcome which enables
use of all observed values in the dataset in a linear mixed-effects model, by making use of an auxil-
iary outcome. There are three new contributions to the literature in this article which we summarize
here. First, we avoid imposing extraneous parametric assumptions, specifications, or restrictions
on the analysis. Instead, we estimate the relationship between the auxiliary outcome and the
true outcome nonparametrically, and develop a regression estimator by extending the estimated
likelihood method (Pepe, 1992) to longitudinal settings. This nonparametric approach produces es-
timates that are robust to misspecification and thus desirable over previously described parametric
and semi-parametric methods. Second, our proposed estimator is shown to be more efficient than
CCA, yet still consistent. The efficiency of the proposed estimator is dependent on the correlation
between auxiliary and true outcomes, with a stronger correlation leading to greater efficiency gains.
However, we will show that this property does not lead to estimates that are less efficient than CCA
estimates, even if the auxiliary and true outcomes are completely uncorrelated. Therefore, use of
our proposed estimator carries the potential benefit of efficiency gains, and does not carry risk of
efficiency loss compared to CCA. Like existing methods, our proposed estimator can potentially
lose efficiency when faced with a large amount of missing data. However, unlike methods which
do not use an auxiliary outcome, much of this efficiency can be regained by choosing an auxiliary
outcome that is strongly correlated with the true outcome. Third, the estimated maximum likelihood
procedure outlined by Pepe (1992) has remained an attractive option for analyzing missing data
since its inception, but it was developed for cross-sectional data and addresses only two types of
subjects: those with an observed outcome and those without. Our proposed method addresses
a third type of subject previously unrecognized in an estimated maximum likelihood method, sub-
jects with an outcome observed at some timepoints, but not all. We develop a novel approach to
incorporate these subjects into the analysis and thus use all available data in our internal validation
procedure. Our proposed method is robust both to non-monotone missingness, and to staggered
timepoints, where subjects may not necessarily attend visits at the same times. We develop and
provide rigorous proof for the asymptotic distribution theory, subject to regularity conditions outlined
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in the appendices. We also provide a consistent estimator for the asymptotic variance.
Section 3.2 of this article outlines the details of the proposed new method. Sections 3.3 and 3.4
corroborate claims with simulation results and a worked data example from the PPMI study. Sec-
tion 3.5 discusses special properties and possible extensions of the proposed method. Additional
simulation results and asymptotic theory are available in Appendix B.2.
3.2. Proposed Methods and Asymptotic Results
Let Y` denote the T x 1 vector of true outcomes for subject ` = 1, . . . , N , where T is the total
number of timepoints on the study and N the total number of subjects. We assume the standard
framework for a linear mixed-effects model (Laird and Ware, 1982), namely that
Y` = X`β + b`Z` + ε`, (3.1)
where for subject `, X` is the design matrix of fixed effects of size T x p, β is the p x 1 vector of
regression coefficients, Z` is the T x q matrix of covariates for the q x 1 vector b` of random effects,
and ε` is the T x 1 vector of random errors. We make two typical assumptions for this type of model.
First, we assume that b` and ε` are independent from each other. Second, we assume that both
ε` and b` have multivariate normal distributions, with mean 0 and variance-covariance matrices
σ2I and D, respectively. Here, D(γ) is a matrix of variance parameters γ for the distribution of
b`. Therefore, the full parameter set for the model is Θ = {β, σ2,D(γ)}. None of the variance
parameters in Θ are assumed to be known; we will focus on β as the parameters of interest, but all
parameters in Θ will be estimated simultaneously in the following procedure.
We partition the total set of subjects into three subsets. Denote V the validation set, containing
subjects i = 1, ..., nV who have a true outcome observed at all T timepoints. The second partition
is V , the hybrid set, containing subjects k = 1, ..., nV having a true outcome observed at least once
but not at all timepoints. Denote Y k the vector of observed outcomes for subject k, of length tk < T .
Finally, V is the nonvalidation set, containing subjects j = 1, ..., nV with true outcome missing at all
T timepoints. nV , nV , and nV are the total number of subjects in each respective set. Throughout
this article, we will strictly adhere to the indices i for subjects in V , k for subjects in V , and j for
subjects in V , with ` reserved for indexing quantities that may apply to more than one subset.
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There are two mechanisms of missing data in the PPMI dataset. First, subjects in V may miss one
or more MRI scans mainly due to scheduling conflicts. Second, the fact that subjects in V have no
MRI scans is due to study design and not related to patient characteristics. A key assumption of the
following proposed methods is that V is a representative subsample of the total population; this is
accomplished if membership in V is determined by an MCAR mechanism. For these subjects, MRI
data are missing because the participating sites do not have the capability to perform high research
quality MRI scans. Thus, we dont have any evidence against the assumption that the validation set
is a random sample of the whole cohort. To further verify this, Schuff et al. (2015) found that the MRI
cohort and non-MRI cohorts were similar in their demographic and disease stage characteristics,
suggesting that the random sample assumption is appropriate for the validation set in the PPMI
study.
Denote S the vector of auxiliary outcomes. We require that all subjects have S recorded at every
timepoint; therefore, S` is of length T for each subject `. We also assume no missing covariates,
and so X` has size T x p for p regression coefficients in the model. Both of these assumptions are
reasonable for the PPMI study, as our auxiliary outcome is constructed from neuropsychological
assessment scores, which are readily available without MRI equipment.
The entire observed data are (Yi,Si,Xi) for subjects in the validation set, (Y k,Sk,Xk) for subjects
in the hybrid set, and (Sj ,Xj) for subjects in the nonvalidation set. The estimated likelihood is then






















Since there is no missing data in V, P̂ (Si|Yi,Xi) in the first term of the likelihood is a constant
with respect to β and can be ignored. We can express the estimated terms in the likelihood by
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As noted in Section 3.1, we aim to develop a nonparametric approach to estimate the relation-
ship between Y and S, in order to avoid assuming or specifying the form of P̂ (Sj |y,Xj). Using
similar arguments as in Pepe (1992), we compute this estimated probability as a ratio of empirical
probabilities,




3.2.1. Estimation Using an Internal Validation Subsample
Because the validation set is a representative subset of the total population, we can estimate the
probability of observing the values of Sj ,y, and Xj in the population by calculating the probability






|H1|−1/2φ(L1(y − Yi,Xj −Xi))
and





|H2|−1/2φ(L2(Sj − Si,y − Yi,Xj −Xi))
where (Sj − Si,y − Yi,Xj − Xi) represents the vectors Si,Yi, and Xi concatenated together,
and subtracted from the vectors Sj ,y,Xj concatenated together. For a model having s covariates,
these vectors are each of length 2T + s. Likewise, the vectors in the construction of P̂ (y,Xj)
are of length T + s. H1,H2 are bandwidth matrices for the kernel function φ, and L1,L2 are the
Cholesky decompositions of H−11 ,H
−1
2 , respectively, such that L
T




2 L2 = H
−1
2 .
All together, the above expressions quantify how well each subject i is “matched” with subject j
using a multivariate kernel function. In all simulations and computations in this manuscript, we use
the multivariate Gaussian kernel, but our proposed method requires only that the chosen kernel
function is symmetric in all dimensions. If the model uses any discrete covariates XD, these
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I(XDj = XDi)|H1|−1/2φ(L1(y − Yi,Xj −Xi))
and





I(XDj = XDi)|H2|−1/2φ(L2(Sj − Si,y − Yi,Xj −Xi))
where XD are the discrete covariates, and all remaining covariates X are continuous.
The contribution to the likelihood for the hybrid set can be constructed in an analogous manner,
integrating over the missing values of Yk. Denote this vector of missing values ymk . For the
probabilities defined thus far for subjects in the nonvalidation set, their counterparts for the hybrid
set are
P̂ (Y k,Sk|Xk) =
∫
P̂β(Y k,Sk,ymk |Xk)dymk =
∫
Pβ(Y k,ymk ,Xk)P̂ (Sk|Y k,ymk ,Xk)dymk ,
P̂ (Sk|Y k,ymk ,Xk) =
P̂ (Sk,Y k,ymk ,Xk)
P̂ (Y k,ymk ,Xk)
,







φ(L1(Y k − YTki,ymk − Ymki,Xk −Xi)),
and







φ(L2(Sk − Si,Y k − YTki,ymk − Ymki,Xk −Xi)),
where YTki denotes the vector of Yi values recorded at the same timepoints as Y k, and Ymki
denotes the counterpart Yi values recorded at the timepoints missed by subject k. For ease of
notation, we use H2 and H1 to represent any possible bandwidth matrices for the numerator and
denominator, respectively, of either P̂ (Sk|Y k,ymk ,Xk) or P̂ (Sj |y,Xj), since the bandwidth can be
chosen arbitrarily.
Using P̂ (Y k,ymk ,Xk) and P̂ (Sk,Y k,ymk ,Xk) to compute P̂β(Y k,Sk|Xk), as well as P̂ (y,Xj)
and P̂ (Sj ,y,Xj) to compute P̂β(Sj |Xj), the estimated likelihood in (3.2) is fully determined. Let the
subscript VS denote estimation using a validation subsample, and set LV S(β) equal to (3.2). Then
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the parameter estimates Θ̂V S are the solution to the corresponding estimated score equations,




∂βPβ(ymk ,Y k|Xk)P̂ (Sk|ymk ,Y k,Xk)dymk , and D̂β(Sj |Xj) =∫
∂















β̂V S is the vector of estimators for the regression coefficients.
3.2.2. Estimation Using Both Hybrid and Validation Subsample
The proposed method as presented in Section 3.2.1 provides an appealing alternative to CCA
when the validation set is not small (see Section 3.3 for simulation results). However, it is not
always practical to assume that a substantial proportion of subjects in a study will have no missing
data. A large number of subjects missing a small number of visits, which results in a relatively small
nV and larger nV , is a common scenario encountered in practice. In such a situation, the internal
validation subsample of Section 3.2.1 would neglect to use most of the observed data. Therefore,
we propose an improvement on this method which takes advantage of all available data to further
improve efficiency of the regression estimates.




































where Vt is the set of all subjects from nV and nV having a true outcome observed at timepoint t,






are the original variables transformed
to induce independence across timepoints, while preserving the original correlations among S,Y ,
andX within the same timepoint. This can be accomplished in the following steps. We first impose






by computing the global variance-covariance matrix,
G, for these variables, and multiplying by the Cholesky decomposition of its inverse. Second, we
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impose the desired covariance structure by specifying a block matrix, B, where the blocks consist
of the variance-covariance structure within each timepoint, with zeros filled in between timepoints.
To summarize, for LTGLG = G
−1 and LTBLB = B
−1, we define an overall matrix Σ
′










Because we have some missing observations in Y , computation of a variance-covariance matrix
using all subjects is not possible. Therefore, taking advantage of the property that V is a represen-
tative subsample of the population, we use only data from V to compute Σ
′
. The estimates for the
variances and covariances contained in Σ
′
are consistent for the true variances and covariances
in the population. After imposing independence across timepoints, we can now multiply the esti-
mated probabilities for each timepoint together to obtain a valid estimate of the overall probability
of observing the values of subject j’s auxiliary outcome and covariates. This estimate is




















since y represents the variable over which we are integrating, there is no need to write y
′
, as the
domain of integration is infinite. Finally, we can define subject j’s contribution to a new likelihood
using this new notation. This contribution is




Just as in Section 3.2.1, the construction of P̂ ′β(Y k,Sk|Xk) for the hybrid set is analogous to the
construction of P̂ ′β(Sj |Xj) described here for the nonvalidation set. An important distinction in the
calculation of P̂ ′β(Y k,Sk|Xk) is that subject k should be left out of the kernel density estimation.
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kt with yt if subject k is missing Ykt. Furthermore,















making the same replacement at each t if Ykt is missing. Finally,
P̂ ′β(Sk,Y k|Xk) =
∫
Pβ(Y k,ymk |Xk)P̂
′(Sk|Y k,ymk ,Xk)dymk .
Having completed the new construction of the estimated portions of the likelihood, we can define a










P̂ ′β(Sj |Xj) (3.3)
The parameter estimates Θ̂HS , where HS denotes estimation using both a hybrid and validation















As in Section 3.2.1, β̂HS is the vector of estimators for the regression coefficients.
It is important to note that the construction of the estimated portions of LV S(β) in Section 3.2.1
relies on the assumption that missing data at the subject level is MCAR; that is, membership in
the nonvalidaton set is based on study randomization and not on the values of the covariates
or outcome. As we explained in Section 3.1, this assumption is reasonable for the PPMI data.
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The MCAR assumption for exclusion from the nonvalidation set ensures that the validation set
is a representative subsample of the total population, and furthermore, ensures that the estimated
probabilities in Section 3.2.1 are valid. However, the estimated probabilities described in this section
also use the hybrid set for kernel density estimation. In the hybrid set, missing values may possibly
be MCAR, but we recognize that assuming an MCAR mechanism in the hybrid set is very restrictive
and not likely to apply in practical settings. However, an MAR (missing at random) assumption is
reasonable for patient dropout in many situations, and the traditional linear mixed-effects model also
carries this assumption. The simulations in Section 3.3 were generated using an MCAR mechanism
for all missing data; however, we evaluated the robustness of β̂HS to MAR data in Tables B.5 and
B.6 of Appendix B.1. These tables demonstrate that MAR data in the hybrid set has little to no
impact on the bias or efficiency of β̂HS . Therefore, the MCAR assumption is necessary only for
exclusion from the nonvalidation set; missing visits in the hybrid set can be MAR.
3.2.3. Asymptotic Properties of the Proposed Estimators
Both
√
N(β̂V S − βV S) and
√
N(β̂HS − βHS) are asymptotically normally distributed as N → ∞
with mean 0. We show in Appendix B.2 that, using arguments similar to those in Pepe (1992), the
variance of the asymptotic distribution for β̂V S is
I−1(β) + I−1(β)

























and ρV , ρV , and ρV are the proportions of V , V , and V in the population, respectively. KV S(β), the











































Qik quantifies how the estimated portion of the score equation for the hybrid set differs from the
true portion of the score equation for the hybrid set. It is estimated as
Q̂ik =
∫ [
|H2|−1/2φ(L2(Sk − Si,Y k − YTki,ymk − Ymki,Xk −Xi))
P̂ (ymk ,Y k,Xk)
−
|H1|−1/2φ(L1(Y k − YTki,ymk − Ymki,Xk −Xi))P̂ (S,ymk ,Y k,Xk)









Likewise, Qij captures how the estimated portion of the score equation for V differs from the true
portion of the score equation for V . Its consistent estimate is
Q̂ij =
∫ [
|H2|−1/2φ(L2(Sj − Si,y − Yi,Xj −Xj))
P̂ (y,Xj)
−










Complete formulas and derivations for KV S(β), Qik, and Qij are given in Appendix B.2.
For the estimator β̂HS , the asymptotic variance is derived analogously. It is
I−1(β) + I−1(β)





where ρV1 = nVt/N for t=1, and the formulas for I(β) and KHS(β) are similar to those for β̂V S .
I(β) is asymptotically equivalent for both estimators, so it can be consistently estimated using
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As before, Q̂′`j and Q̂
′
`k capture the estimation in the score equations.
Q̂′`j =

































∫ [ |H2|−1/2φ(L2(S′k1 − S′`1, Y ′k1 − Y ′`1,X ′k −X ′`))∏Tt=2 P̂ (S′kt, Y ′kt,X ′kt)




































As before, we interchange ymkt and Y
′
kt as appropriate at each t in equation (3.4), dependent on
whether Ykt is observed.
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3.3. Simulations
We conducted a variety of simulations in order to assess the performance of our proposed estima-
tor. We specified a model with uncorrelated random intercepts and slopes, with γ1 and γ2 denoting
the variances of the random intercepts and slopes, respectively. The true outcome Y`, ` = 1, ..., N ,
was simulated according to the model given by (3.1), with σ2=0.9, γ1=1, and γ2=0.5. We included
one continuous baseline covariate, X2 ∼ N(3, 0.16), and a discrete timepoint covariate, X1 = 1,..,T .
Since the amount of missing data can vary in two ways, with the dropout rate in V and the number
of subjects in V , we present a model with two timepoints for clarity of presentation, so that each
subject in V is missing exactly one timepoint.
Define ρV , ρV , and ρV as the proportions nV /N , nV /N , and nV /N , respectively. We setN=350 and
varied ρV between 0.3 and 0.8. Missing data are generated under MCAR. We then determined ρV
and ρV by setting ρV = ρV =
(1−ρV )
2 . As explained in Section 3.1, we expect more efficiency gains
with a stronger correlation between Y and S. To illustrate this, we examined the model using a
strong correlation, 0.8, and a moderate one, 0.4. In Table 3.1, we display both proposed estimators,
β̂V S and β̂HS . These are compared to the estimator from CCA, β̂CC , as well as the Oracle estimator,
β̂O, which uses the full dataset as it would have been available if no data were missing. The relative
efficiency (RE) in Tables 3.1 and 3.2 was calculated by dividing the respective estimated standard
error by the Oracle estimated standard error. RE = 1.0 indicates optimal efficiency, while larger
values of RE indicate efficiency loss. Both β̂CC and β̂O were computed using the lme4 package in
R.
Results from 500 simulations for β̂HS , β̂V S , and β̂CC are displayed in Tables 3.1 and 3.2. Table 3.1
illustrates the efficiency gains on estimates of β1, the regression coefficient for time in the model,
at a strong and a weaker correlation. The bias of all three estimators is very small, as expected.
When the amount of missing data is small (ρV = 0.8), efficiency is close to optimal for β̂HS and β̂V S .
As the amount of missing data increases, β̂CC loses efficiency quite quickly. The two proposed
estimators perform well even in this extreme situation, with β̂HS outperforming β̂V S in all situations.
For the moderate correlation of 0.4, the efficiency is slightly less than optimal with a small amount
of missing data. However, as the amount of missing data increases, both β̂HS and β̂V S tend to lose
efficiency slightly more slowly than β̂CC . Furthermore, β̂HS does not outperform β̂V S here, but it
31
also does not do worse.
Table 3.2 demonstrates the results from the same models for β2, the coefficient for the continuous
baseline covariate. Of note on this table is that the percent bias is higher than that of β1 for all
estimators; however, β̂HS and β̂V S are still on par with β̂CC in terms of bias. The performance of
β̂HS compared to β̂V S is about the same with β2 as with β1, at each respective correlation; that is,
β̂HS gains more efficiency than β̂V S at a strong correlation, but the two are about the same at a
weaker correlation.
Additional simulations are included in Appendix B.1. We demonstrate efficiency of the proposed
estimators under no correlation and perfect correlation between the true and auxiliary outcomes in
Tables B.1 and B.2. We evaluate the performance of PMM and MI estimators under misspecification
of the imputation model and compare this to the robustness of our proposed estimators in Tables
B.3 and B.4. Finally, we evaluate the performance of the proposed estimator β̂HS under MAR in
Tables B.5 and B.6.
3.4. Data Example
Our method is motivated by the data characteristics of PPMI (data retrieved January 2, 2018). The
true outcome, which is missing for some patients, is brain volume as measured by MRI. We illustrate
our method using gray matter (GM) volume from the parietal and frontal lobes, each divided by
total intracranial volume (ICV). Patients underwent MRI scans at baseline and at one year and
two years post-baseline (T=3). Neuropsychological assessments are an ideal choice for auxiliary
outcome, as they do not require specialized equipment to administer, and therefore will be available
for most or all patients. We chose to take advantage of the plethora of information in the PPMI data
by combining a number of these tests into one composite auxiliary variable. We accomplished
this with a linear regression of complete cases at each timepoint, using observed MRI volume
as the outcome and neuropsychological test scores as predictors. We then used the regression
coefficients to predict MRI volume for each subject at each timepoint. This new composite auxiliary
variable has a correlation of 0.52 with the true MRI volume in the parietal lobe, and 0.46 with the
true MRI volume in the frontal lobe. The assessments used in this regression are the Questionnaire
for Impulsive-Compulsive Disorders in Parkinson’s Disease-Rating Scale (QUIP-RS; Weintraub et
al., 2012), Symbol Digit Modalities Score (SDM; Barrett et al., 2019), Semantic Fluency Total Score
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Table 3.1: Results for timepoint coefficient from 500 simulations. SD = standard deviation; ŜE =
estimated standard error; MSE = mean squared error; RE = relative efficiency. β̂HS = estimator
using both hybrid and validation subsample; β̂V S = estimator using an internal validation sample;
β̂CC = complete-case estimator.
Cor(Y ,S) (ρV , ρV , ρV ) Estimator Bias (% Bias) SD ŜE MSE RE
0.8
(0.8, 0.1, 0.1)
β̂HS -0.001 (0.117) 0.085 0.086 0.007 1.069
β̂V S -0.001 (0.111) 0.084 0.007 0.086 1.067
β̂CC -0.001 (0.138) 0.087 0.090 0.008 1.115
(0.7, 0.15, 0.15)
β̂HS -0.001 (0.134) 0.088 0.090 0.008 1.109
β̂V S -0.001 (0.139) 0.088 0.090 0.008 1.110
β̂CC -0.002 (0.164) 0.095 0.096 0.009 1.189
(0.6, 0.2, 0.2)
β̂HS -0.003 (0.328) 0.093 0.094 0.009 1.164
β̂V S -0.003 (0.328) 0.093 0.094 0.009 1.164
β̂CC -0.004 (0.395) 0.102 0.103 0.010 1.281
(0.5, 0.25, 0.25)
β̂HS -0.004 (0.417) 0.098 0.097 0.010 1.205
β̂V S -0.004 (0.358) 0.097 0.100 0.009 1.238
β̂CC -0.006 (0.590) 0.112 0.113 0.013 1.398
(0.4, 0.3, 0.3)
β̂HS -0.006 (0.604) 0.108 0.102 0.012 1.267
β̂V S -0.005 (0.535) 0.109 0.109 0.012 1.347
β̂CC -0.009 (0.874) 0.125 0.126 0.016 1.562
(0.3, 0.35, 0.35)
β̂HS -0.007 (0.670) 0.124 0.108 0.015 1.341
β̂V S -0.006 (0.642) 0.127 0.123 0.016 1.521
β̂CC -0.006 (0.633) 0.149 0.145 0.022 1.794
0.4
(0.8,0.1,0.1)
β̂HS -0.001 (0.124) 0.087 0.090 0.008 1.112
β̂V S -0.001 (0.120) 0.087 0.090 0.008 1.111
β̂CC -0.001 (0.138) 0.087 0.090 0.008 1.115
(0.7,0.15,0.15)
β̂HS -0.001 (0.148) 0.094 0.096 0.009 1.182
β̂V S -0.001 (0.141) 0.094 0.095 0.009 1.180
β̂CC -0.002 (0.164) 0.095 0.096 0.009 1.189
(0.6,0.2,0.2)
β̂HS -0.004 (0.398) 0.101 0.102 0.010 1.267
β̂V S -0.004 (0.389) 0.101 0.102 0.010 1.265
β̂CC -0.004 (0.395) 0.102 0.103 0.010 1.281
(0.5,0.25,0.25)
β̂HS -0.006 (0.569) 0.110 0.111 0.012 1.373
β̂V S -0.006 (0.552) 0.110 0.111 0.012 1.372
β̂CC -0.006 (0.590) 0.112 0.113 0.013 1.398
(0.4,0.3,0.3)
β̂HS -0.009 (0.880) 0.122 0.122 0.015 1.516
β̂V S -0.009 (0.865) 0.122 0.123 0.015 1.521
β̂CC -0.009 (0.874) 0.125 0.126 0.016 1.562
(0.3,0.35,0.35)
β̂HS -0.007 (0.710) 0.143 0.138 0.020 1.708
β̂V S -0.008 (0.790) 0.143 0.140 0.021 1.736
β̂CC -0.006 (0.633) 0.149 0.145 0.022 1.794
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Table 3.2: Results for baseline covariate coefficient from 500 simulations. SD = standard devia-
tion; ŜE = estimated standard error; MSE = mean squared error; RE = relative efficiency. β̂HS =
estimator using both hybrid and validation subsample; β̂V S = estimator using an internal validation
sample; β̂CC = complete-case estimator.
Cor(Y ,S) (ρV , ρV , ρV ) Estimator Bias (% Bias) SD ŜE MSE RE
0.8
(0.8, 0.1, 0.1)
β̂HS -0.026 (3.688) 0.209 0.210 0.044 1.031
β̂V S -0.022 (3.200) 0.209 0.210 0.044 1.033
β̂CC -0.023 (3.267) 0.221 0.215 0.049 1.055
(0.7, 0.15, 0.15)
β̂HS -0.031 (4.469) 0.210 0.212 0.045 1.041
β̂V S -0.026 (3.779) 0.210 0.212 0.045 1.044
β̂CC -0.027 (3.841) 0.228 0.221 0.053 1.089
(0.6, 0.2, 0.2)
β̂HS -0.033 (4.762) 0.213 0.214 0.046 1.053
β̂V S -0.026 (3.770) 0.214 0.215 0.046 1.057
β̂CC -0.032 (4.515) 0.233 0.229 0.055 1.123
(0.5, 0.25, 0.25)
β̂HS -0.035 (5.041) 0.218 0.216 0.049 1.062
β̂V S -0.026 (3.764) 0.221 0.218 0.050 1.070
β̂CC -0.027 (3.843) 0.245 0.237 0.061 1.163
(0.4, 0.3, 0.3)
β̂HS -0.039 (5.621) 0.216 0.218 0.048 1.073
β̂V S -0.029 (4.102) 0.218 0.221 0.048 1.087
β̂CC -0.033 (4.754) 0.247 0.245 0.062 1.204
(0.3, 0.35, 0.35)
β̂HS -0.037 (5.226) 0.226 0.221 0.052 1.085
β̂V S -0.023 (3.219) 0.230 0.226 0.053 1.109
β̂CC -0.030 (4.231) 0.261 0.255 0.069 1.254
0.4
(0.8, 0.1, 0.1)
β̂HS -0.023 (3.265) 0.219 0.217 0.048 1.065
β̂V S -0.023 (3.230) 0.219 0.216 0.048 1.064
β̂CC -0.023 (3.267) 0.221 0.215 0.049 1.055
(0.7,0.15,0.15)
β̂HS -0.027 (3.838) 0.225 0.223 0.051 1.095
β̂V S -0.026 (3.785) 0.225 0.222 0.051 1.093
β̂CC -0.027 (3.841) 0.228 0.221 0.053 1.089
(0.6,0.2,0.2)
β̂HS -0.031 (4.458) 0.230 0.229 0.054 1.127
β̂V S -0.031 (4.367) 0.229 0.229 0.053 1.124
β̂CC -0.032 (4.515) 0.233 0.229 0.055 1.123
(0.5,0.25,0.25)
β̂HS -0.028 (3.934) 0.241 0.236 0.059 1.161
β̂V S -0.027 (3.815) 0.239 0.235 0.058 1.157
β̂CC -0.027 (3.843) 0.245 0.237 0.060 1.163
(0.4,0.3,0.3)
β̂HS -0.033 (4.766) 0.242 0.244 0.060 1.198
β̂V S -0.032 (4.541) 0.240 0.243 0.059 1.193
β̂CC -0.033 (4.754) 0.247 0.245 0.062 1.204
(0.3,0.35,0.35)
β̂HS -0.029 (4.181) 0.254 0.252 0.065 1.239
β̂V S -0.027 (3.818) 0.253 0.251 0.065 1.232
β̂CC -0.030 (4.231) 0.261 0.255 0.069 1.254
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Table 3.3: Summary statistics of baseline measurements. Continuous variables summarized with
mean and standard deviation in parentheses; categorical variables summarized with counts and
percentages in parentheses. GM = gray matter. True GM volume is standardized by dividing by
intracranial volume for each subject, then multiplied by 1000 for clarity of presentation. Composite
GM volume is the auxiliary outcome predicted by clinical assessment scores. MoCA = Montreal
Cognitive Assessment; QUIP-RS = Questionnaire for Impulsive-Compulsive Disorders in Parkin-
son’s Disease Rating Scale; SDM = Symbol Digit Modalities Score; SFT = Semantic Fluency Total
Score; STAI = State-Trait Anxiety Inventory; UPDRS-Cog = cognitive score of Unified Parkinson’s
Disease Rating Scale.
Variable V V V Total
N 119 20 221 360
Gender
Male 77 (64.7%) 15 (75.0%) 146 (66.1%) 238 (66.1%)
Female 42 (35.3%) 5 (25.0%) 75 (33.9%) 122 (33.9%)
GM Volume - Frontal
True 110.9 (11.4) 111.6 (9.3) N/A 111.0 (11.1)
Composite 110.9 (3.5) 112.5 (4.4) 110.2 (4.0) 110.5 (3.9)
GM Volume - Parietal
True 77.3 (8.2) 78.1 (6.9) N/A 77.4 (8.0)
Composite 77.3 (3.2) 78.5 (3.7) 76.7 (3.7) 77.0 (3.5)
Clinical Assessments
MoCA 27.4 (2.1) 28.5 (1.7) 26.8 (2.5) 27.0 (2.3)
QUIP-RS 0.27 (0.56) 0.25 (0.55) 0.29 (0.65) 0.28 (0.62)
SDM 41.4 (9.2) 44.1 (11.0) 40.7 (9.3) 41.1 (9.4)
SFT 49.6 (10.5) 45.0 (10.5) 49.0 (12.6) 49.0 (11.8)
STAI 65.9 (17.8) 66.9 (21.8) 65.3 (18.7) 65.6 (18.6)
UPDRS-Cog 0.32 (0.55) 0.25 (0.64) 0.29 (0.51) 0.29 (0.53)
(SFT; Dadgar, Khatoonabadi, and Bakhtiyari, 2013), State-Trait Anxiety Inventory (STAI; Yang et
al., 2019), the cognitive score of the Unified Parkinson’s Disease Rating Scale (UPDRS; Ibarretxe-
Bilbao et al., 2009; Nagano-Saito et al., 2005), and the Montreal Cognitive Assessment (MoCA;
Nazem et al., 2009). We used separate models for the parietal and frontal lobes. Following this,
we controlled for gender by including it as a covariate in the analysis model. Our scientific aim is to
quantify the longitudinal decline in brain volume in PD patients.
After excluding subjects missing the auxiliary outcome or covariates, we had a cohort of N = 360
subjects, with nV = 221 patients missing all three MRI measurements (ρV = 0.61). 15 patients were
missing one MRI scan, and 5 missing two, leaving nV = 20 and ρV = 0.06. The remaining nV = 119
patients had no missing data (ρV = 0.33). Demographic characteristics are summarized in Table
3.3.
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Table 3.4: β̂HS , β̂V S denote the proposed estimators; β̂CC denotes the complete-case estimator;
ŜE = estimated standard error; Aux. Out. = Auxiliary Outcome; CGMAV = Composite gray matter
auxiliary variable; SDM = Symbol Digit Modalities Score.
Lobe Aux. Out. Cor(S,Y ) Predictor β̂HS(ŜE) β̂V S(ŜE) β̂CC(ŜE)
Parietal
SDM 0.41
Visit -0.754 (0.123) -0.772 (0.121) -0.765 (0.156)
Gender 6.510 (1.143) 6.568 (1.129) 6.754 (1.302)
CGMAV 0.52
Visit -0.775 (0.121) -0.784 (0.121) -0.765 (0.156)
Gender 6.616 (1.077) 6.655 (1.081) 6.754 (1.302)
Frontal
SDM 0.36
Visit -0.611 (0.145) -0.626 (0.141) -0.700 (0.188)
Gender 6.865 (1.607) 7.128 (1.584) 7.127 (1.807)
CGMAV 0.47
Visit -0.639 (0.146) -0.644 (0.147) -0.700 (0.188)
Gender 7.042 (1.542) 7.352 (1.532) 7.127 (1.807)
Results from the analysis model are summarize in Table 3.4. In addition to the composite auxiliary
variable, we also calculated the proposed estimators using the raw Symbol Digit Modalities Score
as the auxiliary variable, since it is the single clinical assessment having the strongest correlation
with MRI volume. The regression coefficient for visit represents annual change in GM volume
measured by MRI. Of note is that both proposed estimators are more efficient than β̂CC , while the
values of β̂HS and β̂V S are similar to β̂CC , which indicates that all three have similar bias. These
results are consistent with the simulations of Section 3.3; for the models where the correlation
between true GM volume and auxiliary variable is slightly better than the moderate correlation of
0.4 used in Section 3.3, we see better efficiency gains than estimators using 0.4 correlation in the
simulations. Furthermore, we expect that β̂HS and β̂V S will perform similarly to each other when
the size of V is small, as is the case in this example.
3.5. Discussion
In this article, we presented a novel methodology to capture the relationship between a true out-
come and predictors in a longitudinal setting which is consistent and more efficient than the conven-
tional method used by most software packages. We have shown through simulations that by using
an auxiliary outcome correlated with the missing outcome, we are able to employ every subject in
the dataset, even those with no true outcome recorded. Additionally, by estimating the relation-
ship between auxiliary and true outcomes nonparametrically, we avoid over-specifying or imposing
additional restrictions on the model.
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We presented two novel estimators in this article; they differ by the manner of nonparametric es-
timation. Section 3.3 demonstrates that both estimators are unbiased, and that, with respect to
efficiency gained, β̂HS is at worst roughly equivalent to and at best superior to β̂V S in all simulated
situations. This result is intuitive and expected, because β̂HS utilizes more observed data in its
construction.
The methodology described in this article has important implications for clinical trials. While re-
sources for clinical trials are notoriously costly, much of this cost can be mitigated with a conser-
vative study design. Typically, investigators anticipate dropout prior to enrollment, and account for
this by enrolling more subjects than the number necessary to achieve desired power. By employing
a method such as ours, which enables use of all enrolled subjects regardless of missing status,
the number of subjects required for enrollment will be smaller. This will lead to valuable savings
in time, money, and other resources, which can translate to better patient care on the trial. Addi-
tionally, some outcomes are difficult and expensive to collect on all patients. For example, lumbar
punctures to collect cerebrospinal fluid are painful and often avoided by patients if possible. Neu-
ropsychological assessments are an inexpensive, painless procedure that can be performed on the
majority of PD patients. By using our proposed method and an auxiliary outcome, investigators can
not only save costs, but also reach more patients.
Our estimator carries the attractive property described in Pepe (1992) that it is not less efficient than
CCA even when the chosen auxiliary outcome is complete uncorrelated with the true outcome. In
the situation where the auxiliary and true outcomes are perfectly correlated, the proposed estimator
is theoretically fully efficient as N → ∞. However, as shown in the simulation results in Appendix
B.1, in finite samples the estimator falls just short of full efficiency. This is easily explained by the
fact that the asymptotic variances of the respective distributions of β̂HS and β̂V S are O(H), shown
in Appendix B.2.
There are some limitations of this method. Because the validation set needs to be representative
of the population in order to avoid bias, the method is best applied to studies where the MCAR
assumption holds. It is reasonable to assume that the missingness mechanism is independent of
covariates in the PPMI study, because inclusion in V is determined by participating study sites.
However, this may not be the case on all clinical trials. Furthermore, we make the assumption that
all subjects will have no missing covariates or missing auxiliary outcome. This implies that, if the
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chosen auxiliary outcome needs to be collected in person and cannot be inferred, patient dropout
can negatively affect the utility of the proposed estimators.
As mentioned previously, the asymptotic variance is O(H). This result has two implications for
the analysis. First, the convergence rate of the estimators is affected by the dimensionality of the
kernel density estimation (Stone, 1980). This dimensionality increases not only with an increasing
number of timepoints, but also with inclusion of additional continuous covariates. In practice, this
may necessitate larger sample sizes for studies with more timepoints or continuous covariates,
particularly if the amount of missing data is large. Secondly, the results of the analysis are sensitive
to choice of H. Pepe (1992) originally claimed that with cross-sectional data, choice of bandwidth
merely affects the rescaling of data, implying that different bandwidths should not result in different
estimates. In our simulations, we found that choice of bandwidth does not affect the bias, but does
impact the efficiency (results not shown). This contrast between cross-sectional and longitudinal
methods suggests that sensitivity to bandwidth increases with an increasing number of timepoints.
In practice, we’ve found that using the optimal bandwidth suggested by Simonoff (1998) achieves
ideal efficiency for the proposed estimators in the situation where the true and auxiliary outcomes
are perfectly correlated (see Appendix B.1). However, at lower correlations, a higher bandwidth is
required to keep the efficiency of the proposed estimator at or above the efficiency of CCA. We’ve
accounted for this anomaly by using an adapted bandwidth, which increases as a function of the
correlation.
While our proposed estimator offers an attractive means to improve efficiency over CCA by using
all available data, we recognize that implementing the method carries practical considerations.
Estimation of the likelihood requires computation of multidimensional integrals with no analytical
form. A wide variety of methods are available to handle such integrations, any of which will require
more computing time with an increasing number of timepoints. For our analysis, we chose to
approximate the integrand using natural cubic splines (Schoenberg, 1946; Birkhoff and Garabedian,




cmprrc - AN R PACKAGE FOR COVARIATE MEASUREMENT ERROR AND
COMPETING RISKS IN FAILURE TIME MODELS
4.1. Introduction
Competing risks have been a popular topic of discussion in time-to-event analyses for a number of
years (Fine and Gray 1999; Moeschberger, Tordoff, and Kochar 2008; Dignam, Zhang, and Kocher-
ginsky 2013). Because it is inherently impossible to measure all survival times in a competing risks
model, there has been some debate about which approach to a competing risks problem is the
appropriate one (Austin and Fine, 2017). The cause-specific hazard approach considers subjects
to be at risk for the event of interest if they have not been censored or experienced competing
events; this approach treats subjects who have experienced competing events the same as cen-
sored subjects. The subdistribution hazard approach (Fine and Gray, 1999) considers all subjects
who have not experienced the event of interest to be at risk for it. This leads to a counterintuitive
risk set, it includes subjects who experienced a competing event (e.g., subjects who died), and are
not at risk for the event of interest in reality. However, the subdistribution hazard approach also
allows for distinction between censored subjects and subjects who experienced a competing event.
This approach also has the attractive quality that as long as the number of subjects experiencing
competing events is bounded away from 0 as N → ∞, the size of the risk set will not approach 0
even at the end of the study. This is a useful property for risk set regression calibration (RRC; Xie,
Wang, and Prentice 2001), as its estimates may become unstable with small risk set sizes.
There are currently a number of R packages in rotation to analyze data in a competing risks frame-
work. Most notably, since cause-specific hazards are calculated identically as the hazard from a
standard Cox model (Cox, 1972), these models can be analyzed using the survival package (Th-
erneau, 2017). Subdistribution hazard models can be analyzed using the cmprsk package (Gray,
2014), developed by the authors of the methodology it implements. However, as noted in Chapter 2,
these packages do not address measurement error, nor do they have the means to accommodate
replicate data. In this chapter, we outline the cmprrc package, developed to implement the methods
of Chapter 2 by addressing competing risks and measurement error in one model. Furthermore,
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although the methods of Chapter 2 focus on the subdistribution hazard approach, our package of-
fers the option to analyze replicate data using RRC combined with cause-specific hazards, should
users feel that a subdistribution hazard approach is not appropriate for the dataset at hand.
4.2. Data
Here we describe the type of data suitable for analysis by this software package. The package can
handle either discrete or continuous failure times T ; however, all failure times must be observed.
Observations without a failure time will be removed from the dataset automatically. As with any
competing risks software package, the user will also need to input the failure type, δ, and the event
type of interest. The model can account for any number of covariates. Although the primary aim
of the package is to account for covariate measurement error, covariates measured without error
can be entered into the model without consequence. The user does not need to specify whether
each covariate is assumed to be measured with error or not; all covariates are treated as if they
are measured with error. If any are truly measured without error, treating them as if they contain
measurement error will not affect the regression estimates.
Furthermore, this package handles replicate data. Each covariate that is assumed to be measured
with error need to have replicates; covariates measured without error do not, similar to the way
baseline covariates need only one recording while time-varying covariates need to be recorded at
each timepoint. Subjects do not need to have the same number of replicates as each other or
at each timepoint. Additionally, the model can handle some subjects having only one replicate.
However, since measurement error is accounted for through replicate data, the number of subjects
having only one replicate should be kept to a minimum, if possible. All data should be entered
into the function in long format; that is, if subject i has covariates observed at M timepoints and ki
replicates at each timepoint, then the subject will have M × ki observations in the dataset.
4.3. Implementation
















where the quantities wj(t), Yj(t) for subjects j = 1, ..., n are the weights and at-risk process, re-
spectively, as defined in Chapter 2. Ẑj(t) are the RRC estimates for covariate Z for subject j
at time t. As noted in Chapter 2, the package converts baseline, time-independent covariates
into a time-dependent RRC covariate estimate. The current version of the package does not ac-
commodate time-varying covariates in the model; however, future iterations should introduce this
update. The parameter estimates β̂C−RRC are those which maximize this estimated likelihood.
The package uses the existing R package optimx to maximize the estimated likelihood, with the
Broyden-Fletcher-Goldfarb-Shanno (BFGS) optimization method specified.
The following arguments are required for the function cmprrc.
Argument Description
data The dataset containing covariates, failure times, and failure
types in long format. Can be a data frame or matrix.
ftimecol An integer indicating which column in the dataset contains
the failure times for each subject.
ftypecol An integer indicating which column in the dataset contains
the failure types for each subject.
type1 An integer indicating which failure type is the event of in-
terest.
covcols A vector of integers denoting which columns in the dataset
contain the covariates for each subject.
subid An integer denoting which column contains the subject
identifiers.
cmpmethod Method to account for competing risks. Options are ”SH” or
”FG” for subdistribution hazards or ”CS” for cause-specific
hazards. Defaults to ”SH”.
siglevel Significance level. Defaults to 0.05.
The function returns the following values after running.
Value Description
coefmat Matrix containing one of each of the following columns: pa-
rameter estimate, standard error, z-statistic, p-value. One
row for each coefficient.
iterations The number of iterations used by optimization.
convcode Convergence code returned from optimization.
ll Log-likelihood value returned from optimization.
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4.4. Performance
The runtime of the function cmprrc was assessed using the R package rbenchmark version 1.0.0
(Kusnierczyk, 2012). We generated data with three covariates, two normally distributed and one
binomially distributed. We specified two situations; in the first, only one of the continuous covariates
is measured with error; in the second, both continuous covariates are. The measurement error
variance σ2 was set at 0.5. We tested these situations with a variety of sample sizes (200, 1000,
and 2000). Results are displayed in Table 4.1. This table displays the average run time from 10
replications for each situation, run on R 3.5.0. The run time increases with increasing number of
subjects; however, accounting for additional covariates with measurement error does not have a
noticeable impact on run time. This implies that datasets with a large number of covariates with
replicates will not adversely impact the run time of the analysis.
Table 4.1: Average run time in seconds of function with varying sample sizes. Each model used 3
covariates. The first column displays results from 1 covariate having measurement error (ME); the
second displays results from 2 covariates having ME. Each cell is the result of 10 runs.






We introduced a new software package for R to implement the regression methods described in
Chapter 2. The package offers a novel method to account for competing risks and covariate mea-
surement error through replicate data. As current competing risks software packages do not handle
replicate data or covariate measurement error, this is a new contribution to the repertoire available
software tools for statisticians and researchers. Dissemination of this R package will make the
method described in Chapter 2 widely available and easy to implement regardless of skill level or
expertise.
We recognize that although the subdistribution hazard method to account for competing risks was
chosen carefully and thoughtfully, it is not the preferred competing risks method for all users. There-
fore, we include an option in cmprrc to account for competing risks by the cause-specific hazard
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method instead. This method handles multiple failure types by treating all competing events as cen-
sored observations. However, we do not outline this option in detail in previous sections, because
the model is mathematically equivalent to the RRC method of Xie, Wang, and Prentice (2001).
The package leaves room for improvement in some areas. First, we only account for baseline
covariates in the model. Future versions of the package will include time-varying covariates. Sec-
ondly, measurement error may also be present in the outcome, where some subjects may have
uncertain failure times. This is a common scenario when the event of interest is not able to be
precisely measured, such as conversion to Alzheimer’s disease in Chapter 2. This is a limitation of




Measurement error and missing data present similar but unique challenges to statistical analyses
by rendering any number of essential quantities unobservable. Although both phenomena have
received some attention in literature for a variety of situations, we identified data properties and
circumstances which remain unaddressed by current methodology. In this dissertation, we offered
contributions to these respective areas of research by developing novel methods that can be applied
to these previously unaccounted-for circumstances.
The first is measurement error in the presence of competing risks for time-to-event analyses. Both
measurement error and competing risks require recognition by investigators and choice of appro-
priate model prior to data analysis; ignoring either one may lead to unexpected or invalid results.
Analyzing data from patients with a neurodegenerative disease such as Alzheimer’s requires proper
framework for both competing risks and measurement error. When a patient exhibits symptoms of
early AD, it is often of interest for the patient and the family to know when that patient can expect
to transition from mild cognitive impairment (MCI) to AD. However, the population of AD patients is
largely elderly, and patients of both normal and MCI status who pass away from comorbidities prior
to converting to AD will not have an observable conversion time. Literature has offered a number
of useful approaches to account for these risks (Fine and Gray 1999; Moeschberger, Tordoff, and
Kochar 2008). Furthermore, the biomarker CSF is prone to measurement error. We also have
adequate methods to account for measurement error in the biomarker (Prentice 1982; Xie, Wang,
and Prentice 2001). However, the lack of a method to account for both will force a researcher to
choose between ignoring measurement error or ignoring competing risks, both of which can lead
to biased results.
The proposed method of Chapter 2 addresses this gap in the literature. We showed that our
proposed estimator almost completely removed the bias incurred by ignoring measurement error
in a competing risks framework, and maintained proper coverage probabilities. This new estimator
was applied to ADNI data to demonstrate its utility in neurodegenerative disease research. We also
assert that this method will prove useful for the research of any disease with high mortality and
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error-prone biomarker measurements.
Our method is not without limitations. Clinical diagnosis of AD is known to be imprecise, and
sometimes even inaccurate (Beach et al., 2012). This can be viewed as a form of measurement
error on the outcome, which is the time to conversion to AD. Since RRC was developed for covariate
measurement error, our method will require a more advanced strategy for addressing measurement
error in both outcome and covariates in order to address the uncertainty in the time to conversion
to AD. Furthermore, our method is only applicable to replicate data, which can be difficult to obtain
if resources are limited. Finally, the regression coefficients of the subdistribution hazard method
can sometimes be difficult to interpret (Austin and Fine, 2017), and may not be preferred by all
investigators. We have addressed this limitation by providing an option in the R package cmprrc
to use the cause-specific hazards approach instead. When combined with RRC, this approach is
mathematically equivalent to using RRC with no competing risks and thus is not acknowledged in
Chapter 2.
The second gap in literature addressed in this dissertation is missing outcome data in longitudinal
settings. Unlike the situations of Chapter 2, missing longitudinal outcome data has not been over-
looked in literature, as many missing data methods are applicable to longitudinal studies (Spratt
et al., 2010). However, we recognize shortcomings with many of these methods, such as the need
to specify a fully parametric or semi-parametric imputation model. Furthermore, these methods
assume a relatively small amount of missing data, which is usually a result only of patient dropout.
Our data are missing at all timepoints for many patients, which implies that use of an auxiliary out-
come available for all patients would be an ideal approach for modeling this data. By estimating the
relationship between auxiliary and true outcomes nonparametrically, we avoid placing any restric-
tions on the imputation model and develop a method which is more robust than standard multiple
imputation. This result is demonstrated in Appendix B.1. Additionally, the simulations of Chapter 3
and Appendix B.1 indicate that our proposed method is more efficient than the conventional CCA
in all situations, and approaches optimal efficiency when the correlation between true and auxil-
iary outcomes is 1. Our proposed method has useful implications for neurodegenerative disease
research, where true outcomes are often costly and difficult to obtain, such as CSF samples and
MRI scans, but auxiliary outcomes are widely available for all subjects, such as neuropsychological
exams.
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The limitations of this method are also addressed in Chapter 3. One limitation is that the MCAR
assumption is necessary for exclusion from the nonvalidation set. Furthermore, the method suffers
from the curse of dimensionality in two ways. First, the estimated likelihood is afflicted by costly
calculations, which can be demanding on computing resources. This pitfall occurs regardless of
the choice of numerical integration method. With a small number of timepoints, the computing time
is reasonable, but quickly becomes impractical as the number of timepoints increases. Planned
improvements to this method involve approximating the integrals in the estimated likelihood by re-
placing each multivariate integral with a product of univariate integrals. This approximation currently
requires more extensive testing before it can be implemented in an R package. The second effect
of high dimensionality on the method lies in the kernel estimation. It has been shown that the
asymptotic rate of convergence slows as the dimension of the kernel increases (Stone, 1980). This
result is corroborated in Appendices B.1 and B.2, where we show both theoretically and through
simulations that the proposed method comes close to, but cannot reach, optimal efficiency in finite
samples due to the bandwidth matrix H. This shortcoming can be mitigated with large sample




APPENDICES FOR CHAPTER 2
A.1. Consistency and Definitions
Using Lemma 1 (Xie, Wang, and Prentice, 2001), consistency and asymptotic normality is achieved
with the estimated quantities used to derive the RRC estimator. µ̂(t), ∆̂, Σ̂(t), µ̂(t), τ̂j(t), and
η̂j(t) each converge uniformly to their respective probability limits µ(t), ∆, Σ(t), τj(t), ηj(t), for
j = 1, 2, ..,l.
Furthermore, the following proofs will utilize the fact that s(p)(β, t), continuous functions of β ∈B,
are bounded on B× [0,M ] for p = 0, 1, 2, again following Lemma 2 in the same reference. s(0)(β, t)
is bounded away from zero, allowing us to consider s(1)(β, t)/s(0)(β, t) and s(2)(β, t)/s(0)(β, t)
bounded functions on B× [0,M ].




n(τ̂k(t)− τk(t)) converge in
distribution to normal random variables, Ckii(k)(t) and D
ki
i(k)(t), respectively, with mean 0 and finite















The above lemmas will be used to establish convergence in probability of Ŝ(p)(β, t) for p = 0, 1, 2.
Denote Qk = {i : ki = k, for i = 1, ..., n} and qk =
∑n
i=1 I(ki = k). Further define ak as the
probability limit of a subject having k replicates, estimated as qk/n. Finally, define Zk(t) as Ẑi(t)
with its estimated components replaced with their probability limits ηk(t) and τk(t). According to









} p−→ G(t)s(p)(β, t) for p = 0, 1, 2






































































































































































Similar results can be established for Ŝ(2)(β, t) p−→ G(t)s(2)(β, t) and Ŝ(0)(β, t) p−→ G(t)s(0)(β, t).
A.2. Martingale Form of Censoring Weights
Assume that time is continuous, and let w̃i(t) = ri(t)G(t)/G(Xi ∧ t), which is the true value of the
censoring weight for subject i. According to Gill (1980), the Kaplan-Meier estimator Ĝ(t) can be
written as a martingale in the following way:
Ĝ(t)
G(t)








G(t) is the survival function associated with the censoring process




M cj (u) is the martingale for the censoring process































− Ĝ(Xi ∧ t)
G(Xi ∧ t)































Ĝ(t)− G(t)Ĝ(Xi ∧ t)
G(Xi ∧ t)




































(A.2) is the form that will be used in the proofs to follow, because in this form it relies on no asymp-
totic assumptions. If we assume n → ∞, then we can use the uniform consistency of Ĝ(·) → G(·)








dM cn(u) + op(1)





dM cn(u) + op(1)
With continuous time, G(u) = G(u−):





dM cn(u) + op(1)









dM cj (u) + op(1)
where π(u) = limn→∞ 1nYn(u) as defined in Fine and Gray.
A.3. Asymptotic Normality of
√
n(Rn(t)− R̃(t))
Here we will show that
√







Ri(t), the sample mean of Ri(t)

























For the first term in (A.3), the central limit theorem applies because the terms are independent
and identically distributed, and because E(Rn(t)) = R̃(t). Therefore, the first term is normally
distributed with mean zero.

































N(t)w̃(t)I(t ≥ u > X)
]
π(u)









We use the standard assumption that π(u) > 0 to guarantee boundedness of H(u), along with
the additional assumption that 1π(u) is predictable with respect to the filtration Ft. Therefore,
by the martingale central limit theorem (Fleming and Harrington, 1991), the predictable variation


















n(Rn(t)− R̃(t)) converges in distribution to a normal
variate with mean 0 and finite variance.
A.4. Asymptotic Normality of β̂C−RRC
In order to replace Ŝ(·) with s(·), we follow the procedure for the robust Cox proportional hazards
model estimator laid out in Theorem II of Lin and Wei (1989). Define R̃(t) and Rn(t) as in Appendix








































































































The final term is op(1) because
√
n{Rn(t) − R̃(t)} is a mean-zero normally distributed random


















































































Therefore, multiplication by Ŝ
(0)(β∗,t)
G(t)s(0)(β∗,t)




































dR̃(t) + op(1) (A.4)



















































































































dR̃(t) + op(1) (A.5)
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The goal is to express (A.5) as a sum of independent, identically distributed random variables. This
can be accomplished by taking steps to replace Ẑi(t) and wi(t) with their known, fixed counterparts
Zi(t) and w̃i(t). Recall that Ẑi(t) = η̂ki(t) + τ̂ki(t)W i. A Taylor expansion of (A.5) around η̂ki(t)
and τ̂ki(t) is now performed. We first break (A.5) into subjects who have the same number of















































Let ηk(t) and τk(t) (dropping subscript i) denote the value of η(t) and τ (t) common to all subjects


































































































Now we perform the Taylor series expansion around ηk(t) and τk(t). We ignore wi(t) for now, since
it is not the case that wi(t)
p−→ w̃i(t). For some |β − β∗| < |β − β̂| and |τ − τ ∗| < |τ − τ̂ |,
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∂τ are continuous, then by the continuous mapping theorem,





































(ηk(t) + τk(t)W i)
}[








(ηk(t) + τk(t)W i)
}

















































































































































































































n(τ̂k(t)− τk(t))dR̃(t) + op(1)


























































































































































Note that φ̃1i(β∗) is similar in form to φ1i(β∗), but φ̃1i(β∗) are independent, identically distributed
random variables, with each estimated component replaced with its known value. We now replace











































































































































I(Xi < u ≤ t)
π(u)













































dM cj (u) + op(1)
The above assumes that regularity conditions hold in the reversal of limits of integration for dM cj (u)
and dNi(t).


















































































































































































































































I(Xi < u ≤ t)
π(u)
}



























−w̃(t)I(t ≥ u > Xi)
π(u)
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W (k)w̃(t)I(X < u ≤ t)
G(t)s(0)(β∗, t)π(u)
]
× E[dM c(u)]dR̃(t) + op(1)





which is delineated with a (k) to indicate dependence on k replicates, and superscript ki to indicate






































































































































Using φi(β∗), we can derive φ̃i(β∗) by substituting all unknown quantities with their probability
limits.





































Although φ̃i(β∗) depends on k through ηk(t) and τk(t), we do not denote it with the k subscript,
because in the estimation procedure we replace Zk(t) with Ẑi(t) and do not require individual
functions that depend on k.
Note that UC−RRC(β∗) is now a sum of independent, identically distributed random variables with
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A second-order Taylor series expansion of UC−RRC(β̂C−RRC) around β∗ yields the following rela-
tion:
√
























By the central limit theorem and Slutsky’s theorem,
√
n(β̂C−RRC − β∗) converges in distribution to
a vector of normal random variables with covariance matrix A(β∗)−1B(β∗)AT (β∗)−1. A(β∗) and


































































































































































where M̂ cj (u) = I(Xj ≤ u,Cj < Tj)−
∫ u
0
I(Xj ≥ t)dΛ̂c(t), π̂(u) = n−1Yn(u), and D̂kii(k)(t) is defined
























Γ̂1(t) =Σ̂(t)Σ̂(t) + ∆̂j
−1−1/Ê(Y1(t))






The asymptotic variance described in simulations is estimated by the above expressions.
A.5. Additional Derivations
The following section details the derivations for quantities described in Xie, Wang, and Prentice




















































































(Wij −W i)(Wij −W i)T ,
ν3 = ν2, and ν4 = ∆
√














































































































































































































Now, each mth term in γ2 is IID over i, because E[I(ki = m)] = am.
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(Wij −W i)(Wij −W i)T
)


































am(m− 1) + op(1).
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am(m− 1) + op(1).
Therefore,
√


































= −γ2 + op(1).
Thus,
√





















































































































































































































































































































































































































































































































































































Substituting (Σ̂−Σ) as well as γ1√
n





APPENDICES FOR CHAPTER 3
B.1. Additional Simulations
To support our claim that our proposed method will not perform worse than the complete case
estimator even if a poor auxiliary outcome is chosen, we assessed these methods using an auxiliary
outcome that is uncorrelated with the true outcome. Using the same simulation setup as Section
3.3, Tables B.1 and B.2 show that both β̂HS and β̂V S perform similarly to β̂CC in terms of both bias
and efficiency when the auxiliary outcome is useless.
We also evaluated the proposed method when the auxiliary outcome is perfectly correlated with
the true outcome. In Tables B.1 and B.2, the efficiency is close to optimal level for β̂HS and β̂V S
when the correlation between Y and S is 1.0. As explained in Section 3.2 of the article and
proved in the following appendix of this supplementary material, efficiency greater than 1 for these
estimators is due to the use of a bandwidth matrix in the kernel density estimation. As the sample
size approaches∞, the efficiency will approach optimality.
We also compared the performance of our proposed method to the gold standard of multiple im-
putation. In Section 3.1, we argue that multiple imputation is subject to misspecification of the
imputation model. To test this, we generated the auxiliary outcome with a quadratic relationship to
the true outcome; we then used the auxiliary outcome, timepoints, and a continuous baseline co-
variate to generate imputed values for the true outcome. We accomplished this using the algorithm
for multiple imputation of a linear mixed-effects model from the mice package version 3.6.0 in R.
The imputation model incorrectly assumes a linear relationship for this model, and as indicated in
Tables B.3 and B.4, this has an impact on the bias. We also compared these results to predictive
mean matching (PMM), which draws from a suitable set of “donors” from the observed outcomes.
We used two PMM estimators, one with 3 donors and one with 10 donors (Schenker and Taylor,
1996; Schenker and Taylor, 1996), and found that both versions are more robust to misspecification
than the MI estimator. Table B.4 shows that PMM performs well in estimating the coefficient for the
baseline covariate, with both bias and standard error remaining low in all situations. However, in
Table B.3 we can see that PMM loses some efficiency in estimating the coefficient for timepoint.
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Table B.1: Results for timepoint coefficient from 500 simulations with a useless auxiliary outcome
and a perfect auxiliary outcome. SD = standard deviation; ŜE = estimated standard error; MSE =
mean squared error; RE = relative efficiency. β̂HS = estimator based on both hybrid and validation
subsample; β̂V S = estimator based on internal validation sample; β̂CC = complete-case estimator.
Cor(Y ,S) (ρV , ρV , ρV ) Estimator Bias (% Bias) SD ŜE MSE RE
0.0
(0.8, 0.1, 0.1)
β̂HS -0.004 (0.360) 0.083 0.090 0.007 1.117
β̂V S -0.004 (0.360) 0.083 0.090 0.007 1.117
β̂CC -0.004 (0.361) 0.083 0.090 0.007 1.116
(0.6, 0.2, 0.2)
β̂HS -0.007 (0.694) 0.097 0.104 0.009 1.285
β̂V S -0.007 (0.695) 0.097 0.104 0.009 1.285
β̂CC -0.007 (0.694) 0.097 0.104 0.009 1.283
(0.5, 0.25, 0.25)
β̂HS -0.006 (0.649) 0.111 0.114 0.012 1.405
β̂V S -0.007 (0.652) 0.111 0.114 0.012 1.404
β̂CC -0.007 (0.652) 0.111 0.114 0.012 1.402
(0.3, 0.35, 0.35)
β̂HS -0.001 (0.087) 0.146 0.146 0.021 1.803
β̂V S -0.001 (0.129) 0.146 0.146 0.021 1.797
β̂CC -0.001 (0.125) 0.147 0.146 0.021 1.799
1.0
(0.8, 0.1, 0.1)
β̂HS -0.006 (0.589) 0.077 0.082 0.006 1.011
β̂V S -0.006 (0.581) 0.076 0.082 0.006 1.010
β̂CC -0.004 (0.361) 0.083 0.090 0.007 1.116
(0.6, 0.2, 0.2)
β̂HS -0.006 (0.604) 0.079 0.083 0.006 1.020
β̂V S -0.006 (0.634) 0.079 0.093 0.006 1.019
β̂CC -0.006 (0.694) 0.097 0.104 0.009 1.283
(0.5, 0.25, 0.25)
β̂HS -0.008 (0.757) 0.079 0.083 0.006 1.025
β̂V S -0.008 (0.773) 0.079 0.083 0.006 1.025
β̂CC -0.007 (0.652) 0.111 0.114 0.012 1.402
(0.3, 0.35, 0.35)
β̂HS -0.005 (0.534) 0.082 0.084 0.007 1.036
β̂V S -0.006 (0.602) 0.082 0.084 0.007 1.036
β̂CC -0.001 (0.125) 0.147 0.146 0.022 1.799
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Table B.2: Results for baseline covariate coefficient from 500 simulations with a useless auxiliary
outcome and a perfect auxiliary outcome. SD = standard deviation; ŜE = estimated standard error;
MSE = mean squared error; RE = relative efficiency. β̂HS = estimator based on both hybrid and
validation subsample; β̂V S = estimator based on internal validation sample; β̂CC = complete-case
estimator.
Cor(Y ,S) (ρV , ρV , ρV ) Estimator Bias (% Bias) SD ŜE MSE RE
0.0
(0.8, 0.1, 0.1)
β̂HS -0.011 (1.609) 0.215 0.217 0.046 1.067
β̂V S -0.011 (1.606) 0.216 0.217 0.046 1.067
β̂CC -0.011 (1.606) 0.216 0.215 0.046 1.054
(0.6, 0.2, 0.2)
β̂HS -0.008 (1.140) 0.224 0.231 0.050 1.135
β̂V S -0.008 (1.137) 0.224 0.231 0.050 1.135
β̂CC -0.008 (1.135) 0.224 0.228 0.050 1.122
(0.5, 0.25, 0.25)
β̂HS -0.009 (1.323) 0.236 0.240 0.056 1.177
β̂V S -0.009 (1.316) 0.236 0.240 0.056 1.176
β̂CC -0.009 (1.318) 0.236 0.237 0.056 1.163
(0.3, 0.35, 0.35)
β̂HS -0.005 (0.654) 0.250 0.258 0.063 1.268
β̂V S -0.005 (0.654) 0.250 0.255 0.063 1.267
β̂CC -0.005 (0.687) 0.250 0.255 0.063 1.252
1.0
(0.8, 0.1, 0.1)
β̂HS -0.012 (1.689) 0.206 0.206 0.043 1.102
β̂V S -0.012 (1.715) 0.206 0.206 0.043 1.012
β̂CC -0.011 (1.606) 0.216 0.215 0.047 1.054
(0.6, 0.2, 0.2)
β̂HS -0.009 (1.219) 0.206 0.207 0.043 1.015
β̂V S -0.008 (1.177) 0.207 0.043 0.043 1.016
β̂CC -0.008 (1.135) 0.224 0.228 0.050 1.112
(0.5, 0.25, 0.25)
β̂HS -0.010 (1.377) 0.208 0.207 0.043 1.016
β̂V S -0.010 (1.377) 0.208 0.207 0.043 1.016
β̂CC -0.009 (1.318) 0.236 0.237 0.056 1.163
(0.3, 0.35, 0.35)
β̂HS -0.006 (0.893) 0.209 0.207 0.044 1.016
β̂V S -0.006 (0.917) 0.209 0.207 0.044 1.016
β̂CC -0.005 (0.687) 0.250 0.255 0.063 1.252
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This is likely due to the nature of the method; PMM imputes missing outcomes from a pool of ob-
served outcomes, and does so by measuring distance between means conditional on covariates.
The method does not account for correlated observations, and this results in efficiency loss in a
longitudinal model.
Finally, as explained in Section 3.2, we evaluated the robustness of β̂HS to MAR outcomes in
the hybrid set. For β̂V S , we require that the validation set be a representative subsample of the
population, in order to ensure that kernel density estimation provides a valid probability estimate.
However, for β̂HS , we also use hybrid set outcomes in the kernel density estimation, and we cannot
guarantee that the hybrid set will have MCAR outcomes. Therefore, we simulated MAR data in the
hybrid set and assessed the performance of β̂HS . With two timepoints, we specified nV , nV , and
nV first, and specified that each subject k miss exactly one outcome. Then, for each subject k ∈ V ,
if Xk ≥ µX , the mean of the distribution of X, we set Yk1 missing with 80% probability. If Xk < µX ,
we specified Yk2 missing with 80% probability. The results in Tables B.5 and B.6 affirm that the bias
and efficiency are not affected by MAR data in the hybrid set, even when the hybrid set is larger
than the validation set.
B.2. Asymptotic Normality of Proposed Estimators
We outline the proof of asymptotic normality here using assumptions similar to Pepe (1992). First,
the proportions nV /N = ρV , nV /N = ρV , nV /N = ρV , and nV1/N = ρV1 are all strictly greater
than 0 as N → ∞. Second, regularity conditions (Cox and Hinkley, 1974) hold for Pβ(Y |X),
Pβ(S,Y |X), and Pβ(S|X). We assume that these probabilities are bounded away from 0 uniformly
in a neighborhood of the true β0, and that their first and second derivatives are bounded. Finally, for
any bandwidth matrix H used to estimate kernel densities in the estimated likelihood, we assume
that N |H| → 0. For more information on this assumption, see (Simonoff, 1998).
B.2.1. Asymptotic Normality of β̂V S
We start by separating the score equation into true and estimated components, with the shorthand
Dβ(Y |X) = ∂∂βPβ(Y |X).
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Table B.3: Results for timepoint coefficient from 500 simulations comparing proposed estimators
with multiple imputation and predictive mean matching estimators. SD = standard deviation; ŜE
= estimated standard error; MSE = mean squared error; RE = relative efficiency. β̂HS = estima-
tor based on both hybrid and validation subsample; β̂V S = estimator based on internal validation
sample; β̂PMM3 = predictive mean matching estimator using 3 donors; β̂PMM10 = predictive mean
matching estimator using 10 donors; β̂MI = multiple imputation estimator; β̂CC = complete-case
estimator.
Cor(Y ,S) (ρV , ρV , ρV ) Estimator Bias (% Bias) SD ŜE MSE RE
0.8
(0.8, 0.1, 0.1)
β̂HS 0.006 (0.553) 0.079 0.096 0.006 1.063
β̂V S 0.003 (0.330) 0.078 0.086 0.006 1.063
β̂PMM3 0.002 (0.203) 0.087 0.1.03 0.008 1.274
β̂PMM10 0.000 (0.203) 0.087 0.102 0.008 1.261
β̂MI 0.020 (2.028) 0.086 0.123 0.008 1.519
β̂CC -0.003 (0.345) 0.084 0.090 0.007 1.116
(0.4, 0.3, 0.3)
β̂HS 0.035 (3.481) 0.102 0.100 0.012 1.238
β̂V S 0.026 (2.581) 0.103 0.104 0.011 1.285
β̂PMM3 -0.003 (0.298) 0.139 0.159 0.019 1.969
β̂PMM10 -0.006 (0.635) 0.135 0.155 0.018 1.911
β̂MI 0.078 (7.812) 0.216 0.486 0.053 6.001
β̂CC -0.006 (0.617) 0.125 0.127 0.016 1.564
0.4
(0.8, 0.1, 0.1)
β̂HS -0.003 (0.265) 0.083 0.090 0.007 1.112
β̂V S -0.003 (0.266) 0.083 0.090 0.007 1.111
β̂PMM3 -0.002 (0.175) 0.090 0.111 0.008 1.372
β̂PMM10 -0.002 (0.207) 0.089 0.110 0.008 1.354
β̂MI 0.021 (2.071) 0.097 0.131 0.053 1.620
β̂CC -0.003 (0.345) 0.084 0.090 0.016 1.116
(0.4, 0.3, 0.3)
β̂HS 0.000 (0.030) 0.121 0.122 0.015 1.511
β̂V S 0.001 (0.096) 0.120 0.123 0.014 1.515
β̂PMM3 -0.009 (0.920) 0.149 0.179 0.022 2.212
β̂PMM10 -0.008 (0.840) 0.148 0.174 0.022 2.145
β̂MI 0.077 (7.709) 0.227 0.227 0.057 2.805
β̂CC -0.006 (0.617) 0.125 0.127 0.016 1.564
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Table B.4: Results for baseline covariate coefficient from 500 simulations comparing proposed esti-
mators with multiple imputation and predictive mean matching estimators. SD = standard deviation;
ŜE = estimated standard error; MSE = mean squared error; RE = relative efficiency. β̂HS = esti-
mator based on both hybrid and validation subsample; β̂V S = estimator based on internal validation
sample; β̂PMM3 = predictive mean matching estimator using 3 donors; β̂PMM10 = predictive mean
matching estimator using 10 donors; β̂MI = multiple imputation estimator; β̂CC = complete-case
estimator.
Cor(Y ,S) (ρV , ρV , ρV ) Estimator Bias (% Bias) SD ŜE MSE RE
0.8
(0.8, 0.1, 0.1)
β̂HS -0.017 (2.385) 0.206 0.209 0.043 1.025
β̂V S -0.012 (1.708) 0.207 0.209 0.043 1.026
β̂PMM3 -0.003 (0.395) 0.215 0.207 0.046 1.018
β̂PMM10 -0.006 (0.789) 0.216 0.207 0.047 1.018
β̂MI -0.016 (2.344) 0.217 0.285 0.047 1.398
β̂CC -0.012 (1.672) 0.215 0.215 0.046 1.054
(0.4, 0.3, 0.3)
β̂HS -0.024 (3.478) 0.214 0.215 0.046 1.057
β̂V S -0.014 (1.960) 0.218 0.218 0.046 1.070
β̂PMM3 0.007 (1.014) 0.251 0.231 0.047 1.134
β̂PMM10 0.002 (0.237) 0.250 0.225 0.047 1.106
β̂MI -0.062 (8.821) 0.937 1.006 0.882 4.941
β̂CC -0.008 (1.173) 0.239 0.245 0.057 1.202
0.4
(0.8, 0.1, 0.1)
β̂HS -0.012 (1.692) 0.214 0.216 0.046 1.062
β̂V S -0.011 (1.592) 0.214 0.216 0.046 1.061
β̂PMM3 -0.009 (1.339) 0.216 0.209 0.047 1.026
β̂PMM10 -0.012 (1.706) 0.217 0.208 0.047 1.024
β̂MI -0.013 (1.843) 0.218 0.265 0.064 1.299
β̂CC -0.012 (1.672) 0.215 0.215 0.060 1.054
(0.4, 0.3, 0.3)
β̂HS -0.010 (1.363) 0.235 0.243 0.055 1.192
β̂V S -0.008 (1.213) 0.233 0.242 0.054 1.188
β̂PMM3 -0.011 (1.554) 0.257 0.237 0.066 1.164
β̂PMM10 -0.013 (1.818) 0.256 0.231 0.066 1.132
β̂MI -0.015 (2.077) 0.285 0.432 0.081 2.119
β̂CC -0.008 (1.173) 0.239 0.245 0.057 1.202
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Table B.5: Results for timepoint coefficient from 500 simulations evaluating impact of MAR out-
comes in the hybrid set. SD = standard deviation; ŜE = estimated standard error; MSE = mean
squared error; RE = relative efficiency. β̂HS = estimator based on both hybrid and validation sub-
sample; β̂CC = complete-case estimator.
Cor(Y ,S) (ρV , ρV , ρV ) Estimator Bias (% Bias) SD ŜE MSE RE
0.8
(0.8, 0.1, 0.1)
β̂HS -0.001 (0.143) 0.085 0.086 0.007 1.060
β̂CC -0.002 (0.187) 0.088 0.089 0.008 1.102
(0.7, 0.15, 0.15)
β̂HS -0.002 (0.167) 0.088 0.088 0.008 1.095
β̂CC -0.003 (0.264) 0.094 0.094 0.009 1.168
(0.6, 0.2, 0.2)
β̂HS -0.004 (0.382) 0.092 0.092 0.008 1.135
β̂CC -0.005 (0.521) 0.100 0.101 0.010 1.245
(0.5, 0.25, 0.25)
β̂HS -0.003 (0.268) 0.094 0.095 0.009 1.181
β̂CC -0.006 (0.562) 0.106 0.108 0.011 1.341
(0.4, 0.3, 0.3)
β̂HS -0.002 (0.230) 0.101 0.100 0.010 1.238
β̂CC -0.008 (0.797) 0.113 0.119 0.013 1.471
(0.3, 0.35, 0.35)
β̂HS -0.007 (0.745) 0.111 0.106 0.012 1.309
β̂CC -0.008 (0.814) 0.131 0.133 0.017 1.647
0.4
(0.8, 0.1, 0.1)
β̂HS -0.002 (0.175) 0.088 0.089 0.008 1.100
β̂CC -0.002 (0.187) 0.088 0.089 0.008 1.102
(0.7, 0.15, 0.15)
β̂HS -0.005 (0.247) 0.093 0.094 0.009 1.163
β̂CC -0.003 (0.264) 0.094 0.094 0.009 1.168
(0.6, 0.2, 0.2)
β̂HS -0.005 (0.509) 0.099 0.100 0.010 1.237
β̂CC -0.005 (0.521) 0.100 0.101 0.010 1.245
(0.5, 0.25, 0.25)
β̂HS -0.005 (0.546) 0.105 0.107 0.107 1.327
β̂CC -0.006 (0.562) 0.106 0.108 0.011 1.341
(0.4, 0.3, 0.3)
β̂HS -0.008 (0.763) 0.111 0.117 0.011 1.447
β̂CC -0.008 (0.797) 0.113 0.119 0.012 1.471
(0.3, 0.35, 0.35)
β̂HS -0.010 (0.983) 0.122 0.130 0.013 1.608
β̂CC -0.008 (0.814) 0.131 0.133 0.017 1.647
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Table B.6: Results for baseline covariate coefficient from 500 simulations evaluating impact of MAR
outcomes in hybrid set. SD = standard deviation; ŜE = estimated standard error; MSE = mean
squared error; RE = relative efficiency. β̂HS = estimator based on both hybrid and validation sub-
sample; β̂CC = complete-case estimator.
Cor(Y ,S) (ρV , ρV , ρV ) Estimator Bias (% Bias) SD ŜE MSE RE
0.8
(0.8, 0.1, 0.1)
β̂HS -0.020 (2.891) 0.212 0.211 0.050 1.039
β̂CC -0.021 (3.071) 0.225 0.217 0.051 1.067
(0.7, 0.15, 0.15)
β̂HS -0.021 (3.006) 0.214 0.215 0.053 1.055
β̂CC -0.023 (3.321) 0.232 0.225 0.054 1.107
(0.6, 0.2, 0.2)
β̂HS -0.028 (4.008) 0.216 0.217 0.056 1.069
β̂CC -0.032 (4.632) 0.237 0.234 0.057 1.152
(0.5, 0.25, 0.25)
β̂HS -0.023 (3.265) 0.223 0.221 0.062 1.087
β̂CC -0.028 (3.974) 0.252 0.245 0.064 1.205
(0.4, 0.3, 0.3)
β̂HS -0.023 (3.250) 0.232 0.225 0.066 1.107
β̂CC -0.024 (3.393) 0.261 0.257 0.069 1.262
(0.3, 0.35, 0.35)
β̂HS -0.024 (3.489) 0.236 0.229 0.070 1.125
β̂CC -0.028 (4.019) 0.271 0.272 0.074 1.334
0.4
(0.8, 0.1, 0.1)
β̂HS -0.021 (3.032) 0.223 0.219 0.050 1.076
β̂CC -0.021 (3.071) 0.225 0.217 0.051 1.067
(0.7, 0.15, 0.15)
β̂HS -0.023 (3.262) 0.229 0.227 0.053 1.115
β̂CC -0.023 (3.321) 0.232 0.225 0.054 1.107
(0.6, 0.2, 0.2)
β̂HS -0.032 (4.587) 0.234 0.235 0.056 1.154
β̂CC -0.032 (4.632) 0.237 0.234 0.057 1.152
(0.5, 0.25, 0.25)
β̂HS -0.027 (3.911) 0.247 0.245 0.062 1.202
β̂CC -0.028 (3.974) 0.252 0.245 0.064 1.205
(0.4, 0.3, 0.3)
β̂HS -0.024 (3.402) 0.256 0.256 0.066 1.255
β̂CC -0.024 (3.393) 0.261 0.257 0.069 1.262
(0.3, 0.35, 0.35)
β̂HS -0.029 (4.160) 0.263 0.268 0.070 1.315
































































































P̂ (Sj |y,Xj)ψβ,Vj (y)dy + op(1).
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Now invoking Slutsky’s Theorem again, and noting that
∫





P̂ (Sj |y,Xj)− P (Sj |y,Xj)
}




















− P (Sj ,y,Xj)P̂ (y,Xj)
P 2(y,Xj)
}
ψβ,Vj (y)dy + op(1).
At this point, we can express P̂ (Sj ,y,Xj) and P̂ (y,Xj) in terms of their respective constructions
kernel density estimates,















φ(L1(y − Yi,Xj −Xj))
Let φ(L2(Sj −Si,y − Yi,Xj −Xi)) = φ2j and φ(L1(y − Yi,Xj)) = φ1j , for clarity of presentation.
Without loss of generality, if there are discrete covariates in the model, then let φ2j = I(XDj =































































φ2ik = φ(L2(Sk − Si,ymk − Ymki,Y k − YTki,Xk −Xk)),





P (ymk ,Y k,Xk)
− |H1|
−1/2φ1ikP (Sk,ymk ,Y k,Xk)





k (ymk ,Y k) =
Dβ(ymk ,Y k|Xk)
Pβ(Sk,Y k|Xk)
− Dβ(Sk,Y k|Xk)P (ymk ,Y k|Xk)
P 2β(Sk,Y k|Xk)
.
Putting (B.1) and (B.2) together,
































Therefore, multiplying by 1√
N





































The next part of the proof is to establish the expected value ofQi conditional on the validation data.
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∣∣J(u,v,w)∣∣dudvdw = ∣∣L−12 ∣∣dudvdw.
We then make the substitution and note that |L−12 | = |H2|1/2. We also note here that
(S,y,X) = L−12 (u,v,w) + (Si,Yi,Xi)












with the superscript denoting the respective columns of L−12 corresponding to that variable. Simi-
larly, we can make a substitution on the second integral in (B.3a) with (u,v) = L1(y−Yi,X −Xi),

































































We write simply O(H) to denote a function on the same order as the chosen bandwidth. Since,
by assumption, the bandwidth matrix approaches 0 as N approaches ∞, these functions are also
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Dβ(S|Xi + (L−11 )Xv)
Pβ(S|Xi + (L−11 )Xv)
×





























































Using arguments similar to those in Pepe (1992), conditional on the validation data Si,Yi,Xi, each
Qi is a sum over V and V of independent, identically distributed random variables. Therefore, they
converge in probability to their mean E[Qi|Si,Yi,Xi], and their variance is V ar(Qi|Si,Yi,Xi),
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which converges in probability to V ar(E[Qi|Si,Yi,Xi]), defined in Section 3.2 as KV S(β).
Conversely, if we condition on the observed data in V and V , then it is trivial to show that Qi is
a sum over V of independent, identically distributed random variables with mean 0 (see equation
(B.2)). Finally, by the Lyapunov central limit theorem (Billingsley, 1986), the conditional distribution
of 1√
N
UV S(β) is asymptotically normal with mean 0 and variance
I(β) +




with I(β) as defined in Section 3.2. By Taylor expansion, β̂V S is then asymptotically normal with
mean 0 and variance
I(β)−1 +





Consistent estimates for these quantities are given in Section 3.2.1.
B.2.2. Asymptotic Normality of β̂HS






























































ψβ,Vj (y)dy + op(1).
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We now use P̂ ′(S,y,X) and P̂ ′(y,X) as defined in Section 3.2.2.


























































By the Continuous Mapping Theorem and Slutsky’s Theorem, and using the consistency of these






































and Pt = P (yt,Xjt) for t = 1, 2. We know that these are consistent estimates; i.e.,
P̂ ′ t
p−→ Pt for t = 1, 2.
Now specify a continuous, differentiable function such that
g(P1, P2) = P1P2










Finally, by Slutsky’s Theorem,
(P̂ ′1 − P1)(P̂ ′2 − P2)
p−→ 0.







2 ± P̂ ′1P2 ± P1P̂ ′2 ± P1P2
=(P̂ ′1P̂
′
2 − P̂ ′1P2 − P1P̂ ′2 + P1P2) + P̂ ′1P2 + P1P̂ ′2 − P1P2
=(P̂ ′1 − P1)(P̂ ′2 − P2) + (P̂ ′1P2 + P1P̂ ′2 − P1P2)
=(P̂ ′1 − P1)(P̂ ′2 − P2) + (P̂ ′1P2 + P1[P̂ ′2 − P2])
=P̂ ′1P2 + op(1).










































































j (y)dy + op(1).
We can use similar arguments to derive the formula for Q`k. As mentioned in Section 3.2.2, the







P̂ ′(Sk,ymk ,Y k,Xk)
P̂ ′(ymk ,Y k,Xk)







































t=2 P (Skt, yt,Xkt)




1`kP (Sk,ymk ,Y k,Xk)
∏N
t=2 P (yt,Xkt)



















Furthermore, if subject k is missing the true outcome, then replace 1nV1−1 with
1
nV1
, because then k
is not a member of V1. Since this will not affect more than one subject, this nuance has no impact
on the variance as N → ∞. To establish E[Q`|S`,Y`,X`], repeat the same integration steps as
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with Qi in Section B.2.1.
































































Since choice of the bandwidth matrix H is flexible, we recommend accounting for Σ
′
in the choice
of H, by multiplying the original choice of H by Σ
′TΣ
′
. This will simplify the integral below, since
we will not need to consider the additional matricesL−1B LG in the u-substitution. Again, we continue











































































































































































































With similar steps for E
[
Q`k







































































Using the same arguments as in Section B.2.1, the variance of the score equation is I(β) +






`∈V1 Q`. Finally, the asymptotic variance of β̂HS , the
solution to UHS(β), is
I−1(β) +
(






B.3. Additional Details on Natural Cubic Splines
As there is no analytical integral for P̂ (Sj |Xj) or P̂ (Sk|Y k,Xk), numerical integration techniques
were required to calculate these quantities. The dimension of the integral for each subject j is equal
to the number of missing observations for subject j. Due to the complexity of the integrand for
these quantities, many numerical integration methods are not practical for more than one missing
observation per subject, due to exponentially increased computing time. Therefore, the results
presented in this dissertation were obtained not by approximating the value of the integral with
numerical integration, but by approximating the integrand with a natural cubic spline. The cubic
spline is constructed in the following way. All notation defined here is unique to this appendix.





S0(x) = a0 + b0(x− xi) + c0(x− xi)2 + d0(x− xi)3 x0 ≤ x ≤ x1
S1(x) = a1 + b1(x− xi) + c1(x− xi)2 + d1(x− xi)3 x1 ≤ x ≤ x2
S2(x) = a2 + b2(x− xi) + c2(x− xi)2 + d2(x− xi)3 x2 ≤ x ≤ x3
...
Sn−1(x) = an−1 + bn−1(x− xi) + cn−1(x− xi)2 + dn−1(x− xi)3 xn−1 ≤ x ≤ xn
S(x) is also subject to the following conditions:
1. Interpolating data: Si(xi) = yi, i = 0, 1, .., n.
2. Continuity at interior points: Si(xi+1) = Si+1(xi+1), i = 0, 1, ..., (n− 2).
3. Continuity of slope at interior points: S
′
i (xi+1) = S
′
i+1(xi+1), i = 0, 1, ..., (n− 2).
4. Continuity of curvature at interior points: S
′′
i (xi+1) = S
′′
i+1(xi+1), i = 0, 1, ..., (n− 2).
5. Natural cubic spline condition: S
′′
0 (x0) = 0 and S
′′
n−1(xn) = 0.
From here, a system of equations can be set up in order to solve for ai, bi, ci, and di. Condition 1
implies Si(xi) = ai = yi, i = 0, 1, ..., (n− 1), and Sn−1(xn) = yn, as well as
yn−1 + bn−1(xn − xn−1) + cn−1(xn − xn−1)2 + dn−1(xn − xn−1)3 = yn.
Condition 2 implies
yi + bi(xi+1 − xi) + ci(xi+1 − xi)2 + di(xi+1 − xi)3 = yi+1, i = 0, 1, ..., (n− 2).
From condition 3, we have
bi + 2ci(xi+1 − xi) + 3di(xi+1 − xi)2 = bi+1, i = 0, 1, ..., (n− 2).
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Finally, from condition 4, we have
2ci + 6di(xi+1 − xi) = 2ci+1, i = 0, 1, ..., (n− 2),
and the natural spline condition implies
2c0 = 0 and 6dn−1(xn − xn−1) + 2cn−1 = 0.
Writing hi = xi+1 − xi, i = 0, 1, ..., (n− 1), and vectors a, b, c, and d, we can construct a system of
equations to solve for the coefficients of S(x). First, solve Ac = v for c, where
A =

1 0 0 0 . . . 0 0 0
h0 2(h0 + h1) h1 0 . . . 0 0 0








0 0 0 0 . . . hn−2 2(hn−2 + hn−1) hn−1








































i = 0, 1, ..., (n− 1).
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Once all coefficients are obtained, P̂ (Sj |Xj) can be approximated as
P̂ (Sj |Xj) =
∫
P̂ (Sj |y,Xj)Pβ(y|X)dy ≈
∫
S(x)dx.
S(x) has a closed-form integral, which is
n−1∑
i=1
ai(xi+1 − xi) +
1
2
bi(xi+1 − xi)2 +
1
3




and now the likelihood can be calculated in full for one missing observation per subject. For a linear
mixed-effects model, the missing outcome is assumed to be normally distributed, and thus has an
infinite domain. This may seem to be problematic, as the cubic spline is defined over a finite set of
intervals and thus the integral of S(x) cannot be an indefinite integral. However, since the kernel
function of P̂ (Sj |y,Xj) is 0 for large inputs, P̂ (Sj |y,Xj)Pβ(y|Xj) is only nonzero over some finite
domain. Therefore, in order to appropriately approximate P̂ (Sj |y,Xj)Pβ(y|Xj) with S(x), we need
only to define S(x) over a wide enough domain such that all inputs resulting in a nonzero function
value are contained within the specified domain of S(x).
In order to extend the method to two missing observations per subject, the cubic spline must be
extended to two dimensions, a case often referred to as a thin plate spline. The extension is
straightforward. The cubic spline is expressed as a plane in two dimensions, x and y, for data
points (xi, yj , zij), i = 0, 1, ..., n, j = 0, 1, ..., n. The piecewise cubic thin plate spline S(x, y) is now
Sij(x, y) =aij + bij(x− xi) + cij(x− xi)2 + dij(x− xi)3 + eij(y − yj) + fij(y − yj)2
+ gij(y − yj)3, xi ≤ x ≤ xi+1, yj ≤ y ≤ yj+1
for i = 0, 1, ...(n− 1), j = 0, 1, ..., (n− 1).
Conditions 1 through 5 are also extended:
1. Interpolating data: Sij(xi, yj) = zij , i = 0, 1, .., n, j = 0, 1, ..., n.
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2. Continuity at interior points:
Sij(xi+1, yj) = Si+1,j(xi+1, yj)
Sij(xi, yj+1) = Si,j+1(xi, yj+1)
i = 0, 1, ..., (n− 2), j = 0, 1, .., (n− 2).
3. Continuity of slope at interior points:
S
′





ij(xi, yj+1) = S
′
i,j+1(xi, yj+1)
i = 0, 1, ..., (n− 2), j = 0, 1, .., (n− 2).
4. Continuity of curvature at interior points:
S
′′





ij(xi, yj+1) = S
′′
i,j+1(xi, yj+1)
i = 0, 1, ..., (n− 2), j = 0, 1, .., (n− 2).
5. Natural cubic spline condition:
S
′′
00(x0, y0) = 0
S
′′
0j(x0, yj) = 0
S
′′
i0(xi, y0) = 0
S
′′
n−1,j(xn, yj) = 0
S
′′
i,n−1(xi, yn) = 0
S
′′
n−1,n−1(xn, yn) = 0
i = 0, 1, ..., n, j = 0, 1, .., n.
Now, define hi = (xi+1 − xi) and kj = (yj+1 − yj). Further define cj as the vector of coefficients
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cij for i = 0, 1, ..., n, and fi as the vector of coefficients fij for j = 0, 1, ..., n. Define bj , dj , ei,
and gi likewise. We can solve for cj using equations Acj = vj , and additionally solve for fi using
equations Bfi = wi, where
B =

1 0 0 0 . . . 0 0 0
k0 2(k0 + k1) k1 0 . . . 0 0 0








0 0 0 0 . . . kn−2 2(kn−2 + kn−1) kn−1













































































i = 0, 1, ..., (n− 1), j = 0, 1, ..., (n− 1).
Now, P̂ (Sj |y,Xj) can be approximated for two missing observations per subject as the integral of






zij(xi+1 − xi)(yj+1 − yj) +
1
2
bij(xi+1 − xi)2(yj+1 − yj) +
1
3




dij(xi+1 − xi)4(yj+1 − yj) +
1
2
eij(xi+1 − xi)(yj+1 − yj)2 +
1
3




gij(xi+1 − xi)(yj+1 − yj)4
]
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